@article {pmid35763567,
year = {2022},
author = {Mahas, A and Marsic, T and Lopez-Portillo Masson, M and Wang, Q and Aman, R and Zheng, C and Ali, Z and Alsanea, M and Al-Qahtani, A and Ghanem, B and Alhamlan, F and Mahfouz, M},
title = {Characterization of a thermostable Cas13 enzyme for one-pot detection of SARS-CoV-2.},
journal = {Proceedings of the National Academy of Sciences of the United States of America},
volume = {119},
number = {28},
pages = {e2118260119},
doi = {10.1073/pnas.2118260119},
pmid = {35763567},
issn = {1091-6490},
support = {NTGC//King Abdullah University of Science and Technology (KAUST)/ ; RTF//King Abdullah University of Science and Technology (KAUST)/ ; R3T//King Abdullah University of Science and Technology (KAUST)/ ; },
abstract = {Type VI CRISPR-Cas systems have been repurposed for various applications such as gene knockdown, viral interference, and diagnostics. However, the identification and characterization of thermophilic orthologs will expand and unlock the potential of diverse biotechnological applications. Herein, we identified and characterized a thermostable ortholog of the Cas13a family from the thermophilic organism Thermoclostridium caenicola (TccCas13a). We show that TccCas13a has a close phylogenetic relation to the HheCas13a ortholog from the thermophilic bacterium Herbinix hemicellulosilytica and shares several properties such as thermostability and inability to process its own pre-CRISPR RNA. We demonstrate that TccCas13a possesses robust cis and trans activities at a broad temperature range of 37 to 70 °C, compared with HheCas13a, which has a more limited range and lower activity. We harnessed TccCas13a thermostability to develop a sensitive, robust, rapid, and one-pot assay, named OPTIMA-dx, for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection. OPTIMA-dx exhibits no cross-reactivity with other viruses and a limit of detection of 10 copies/μL when using a synthetic SARS-CoV-2 genome. We used OPTIMA-dx for SARS-CoV-2 detection in clinical samples, and our assay showed 95% sensitivity and 100% specificity compared with qRT-PCR. Furthermore, we demonstrated that OPTIMA-dx is suitable for multiplexed detection and is compatible with the quick extraction protocol. OPTIMA-dx exhibits critical features that enable its use at point of care (POC). Therefore, we developed a mobile phone application to facilitate OPTIMA-dx data collection and sharing of patient sample results. This work demonstrates the power of CRISPR-Cas13 thermostable enzymes in enabling key applications in one-pot POC diagnostics and potentially in transcriptome engineering, editing, and therapies.},
}

@article {pmid35763226,
year = {2022},
author = {Kahraman-Ilıkkan, Ö},
title = {Comparison of Propionibacterium genomes: CRISPR-Cas systems, phage/plasmid diversity, and insertion sequences.},
journal = {Archives of microbiology},
volume = {204},
number = {7},
pages = {434},
pmid = {35763226},
issn = {1432-072X},
abstract = {The clustered regularly interspaced short palindromic repeats (CRISPR)-Cas systems constitute the adaptive immune system in prokaryotes that provide resistance against invasive genetic elements. The genus Propionibacterium comprises gram-positive, facultative anaerobe, non-spore-forming bacteria, and is the source of some B group vitamins such as B12 as well as bacteriocins. Some of the selected species of the genus Propionibacterium spp. were reclassified into the three genera in 2016 (Acidipropionibacterium spp., Pseudopropionibacterium spp., Cutibacterium spp.). Therefore, this study compared CRISPR/Cas systems, Cas 1 and repeat sequences phylogeny, phage/plasmid surveys as well as insertion sequences of new genera members. In this study, a total of 34 genomes of 13 species were observed with a bioinformatic approach. CRISPR-Cas + + and CRISPRDetect were used to detect CRISPR/Cas systems, direct repeats, and spacers. 39 CRISPR-Cas systems were detected. Type I-E, Type I-U, and one incomplete III-B CRISPR-Cas subtypes were identified. Most of the strains had Cas1/Cas4 fusion proteins. Pseudopropionibacterium propionicum strains had two types I-U and one of the CRISPR loci had csx17 cas genes. Common phage invaders were Propionibacterium phage E6, G4, E1, Anatole, and Doucette. The BLSM62 similarity score of all Cas1 sequences was 48.4% while the pairwise identity of repeat sequences was 48.7%. Common insertion sequences were ISL3, IS3, IS30. The diversity analysis of the CRISPR/Cas system in the genus Propionibacterium provided a new perspective for determining the role of the CRISPR-Cas system in the evolution of new genera.},
}

@article {pmid35762550,
year = {2022},
author = {Khan, IS and Faiyaz, Z and Khan, AU},
title = {Use Of Crispr In Infection Control.},
journal = {Current protein & peptide science},
volume = {},
number = {},
pages = {},
doi = {10.2174/1389203723666220627152112},
pmid = {35762550},
issn = {1875-5550},
abstract = {One of the greatest threats of the global world is infectious diseases. The morbidity and fatality of infectious diseases causes 17 million deaths annually. The recent COVID-19 pandemic describes the uncertain potential of these diseases. Understanding the pathogenesis of infectious agents, including bacteria, viruses, fungi, etc. and the evolution of rapid diagnostic techniques and treatments has become a pressing priority to improve infectious disease outcomes worldwide. Clustered regularly interspaced short palindromic repeats (CRISPR) constitutes the adaptive immune system of archaea and bacteria along with CRISPR-associated (Cas) proteins that recognizes and destroys foreign DNA acting as molecular scissors. Since their discovery, CRISPR systems are classified into 6 types and 22 subtypes. The type II, V and VI are used for diagnostic purposes. This potential of the CRISPR-Cas system is being used to create innovative delivery systems, to access interactions between hosts and pathogens, which helps develop new and improved diagnostics and further advance to prevent and treat infectious diseases.},
}

@article {pmid35751058,
year = {2022},
author = {Jiang, J and Zeng, T and Zhang, L and Fan, X and Jin, Q and Ni, H and Ye, Y and Cheng, L and Li, L and Wang, L and Xu, S and Yang, Y and Gu, J and Guo, B and Wang, L and Li, X and Qin, Y and Li, J and Wang, J and Chen, X and Wu, M and Ying, QL and Qin, X and Wang, Y and Wang, Y},
title = {Optimization of Cas9 RNA sequence to reduce its unexpected effects as a microRNA sponge.},
journal = {Molecular cancer},
volume = {21},
number = {1},
pages = {136},
pmid = {35751058},
issn = {1476-4598},
support = {2018YFA0108300//National Key Research and Development Program of China Stem Cell and Translational Research/ ; 81972397//National Natural Science Foundation of China/ ; 31971109//National Natural Science Foundation of China/ ; 31471390//National Natural Science Foundation of China/ ; 81600926//National Natural Science Foundation of China/ ; 14DZ2272300//Shanghai Key Laboratory of Cell Engineering/ ; 17QA1405400//Shanghai Rising-Star Program/ ; 2017YQ028//Shanghai Municipal Population and Family Planning Commission/ ; },
mesh = {Base Sequence ; CRISPR-Cas Systems ; Gene Editing ; HeLa Cells ; Humans ; *MicroRNAs/genetics ; },
}

Base Sequence
CRISPR-Cas Systems
Gene Editing
HeLa Cells
Humans
*MicroRNAs/genetics

@article {pmid35750764,
year = {2022},
author = {Miskel, D and Poirier, M and Beunink, L and Rings, F and Held, E and Tholen, E and Tesfaye, D and Schellander, K and Salilew-Wondim, D and Blaschka, C and Große-Brinkhaus, C and Bertram, B and Hoelker, M},
title = {The cell cycle stage of bovine zygotes electroporated with CRISPR/Cas9-RNP affects frequency of Loss-of-heterozygosity editing events.},
journal = {Scientific reports},
volume = {12},
number = {1},
pages = {10793},
pmid = {35750764},
issn = {2045-2322},
mesh = {Animals ; *CRISPR-Associated Protein 9/genetics ; CRISPR-Cas Systems/genetics ; Cattle ; Cell Division ; Electroporation/methods ; Gene Editing/methods ; Mammals/metabolism ; Ribonucleoproteins/metabolism ; *Zygote/metabolism ; },
abstract = {At the embryonic level, CRISPR technologies have been used to edit genomes reliably and efficiently in various mammalian models, with Ribonucleoprotein (RNP) electroporation potentially representing a superior delivery method into mammalian zygotes. However, detailed insights of the interactions between varying technical settings as well as the time point of electroporation in a bovine zygote's cell cycle on developmental metrics and the frequency and type of editing events are largely unknown. The present study uncovers that increasing pulse lengths result in higher Full Edit rates, with Mosaicism in Full-Edit embryos being significantly affected by adjusting RNP-electroporation relative to zygote cell cycle. A considerable proportion of Full Edit embryos demonstrated loss-of-heterozygosity after RNP-electroporation prior to S-phase. Some of these loss-of-heterozygosity events are a consequence of chromosomal disruptions along large sections of the target chromosomes making it necessary to check for their presence prior use of this technique in animal breeding. One out of 2 of these loss-of-heterozygosity events, however, was not associated with loss of an entire chromosome or chromosomal sections. Whether analysed loss-of-heterozygosity in these cases, however, was a false negative result due to loss of PCR primer sequences after INDEL formation at the target side or indeed due to interhomolog recombination needs to be clarified in follow up studies since the latter would for sure offer attractive options for future breeding schedules.},
}

Animals
*CRISPR-Associated Protein 9/genetics
CRISPR-Cas Systems/genetics
Cattle
Cell Division
Electroporation/methods
Gene Editing/methods
Mammals/metabolism
Ribonucleoproteins/metabolism
*Zygote/metabolism

@article {pmid35666156,
year = {2022},
author = {Kang, M and Zuo, Z and Yin, Z and Gu, J},
title = {Molecular Mechanism of D1135E-Induced Discriminated CRISPR-Cas9 PAM Recognition.},
journal = {Journal of chemical information and modeling},
volume = {62},
number = {12},
pages = {3057-3066},
doi = {10.1021/acs.jcim.1c01562},
pmid = {35666156},
issn = {1549-960X},
mesh = {*CRISPR-Associated Protein 9/chemistry/genetics/metabolism ; CRISPR-Cas Systems/genetics ; DNA/chemistry ; *RNA, Guide/chemistry/genetics ; Streptococcus pyogenes/genetics/metabolism ; },
abstract = {The off-target effects of Streptococcus pyogenes Cas9 (SpCas9) pose a significant challenge to harness it as a therapeutical approach. Two major factors can result in SpCas9 off-targeting: tolerance to target DNA-guide RNA (gRNA) mismatch and less stringent recognition of protospacer adjacent motif (PAM) flanking the target DNA. Despite the abundance of engineered SpCas9-gRNA variants with improved sensitivity to target DNA-gRNA mismatch, studies focusing on enhancing SpCas9 PAM recognition stringency are quite few. A recent pioneering study identified a D1135E variant of SpCas9 that exhibits much-reduced editing activity at the noncanonical NAG/NGA PAM sites while preserving robust on-target activity at the canonical NGG-flanking sites (N is any nucleobase). Herein, we aim to clarify the molecular mechanism by which this single D1135E mutation confers on SpCas9 enhanced specificity for PAM recognition by molecular dynamics simulations. The results suggest that the variant maintains the base-specific recognition for the canonical NGG PAM via four hydrogen bonds, akin to that in the wild type (WT) SpCas9. While the noncanonical NAG PAM is engaged to the two PAM-interacting arginine residues (i.e., R1333 and R1335) in WT SpCas9 via two to three hydrogen bonds, the D1135E variant prefers to establish two hydrogen bonds with the PAM bases, accounting for its minimal editing activity on the off-target sites with an NAG PAM. The impaired NAG recognition by D1135E SpCas9 results from the PAM duplex displacement such that the hydrogen bond of R1333 to the second PAM base is disfavored. We further propose a mechanistic model to delineate how the mutation perturbs the noncanonical PAM recognition. We anticipate that the mechanistic knowledge could be leveraged for continuous optimization of SpCas9 PAM recognition specificity toward high-precision demanding applications.},
}

*CRISPR-Associated Protein 9/chemistry/genetics/metabolism
CRISPR-Cas Systems/genetics
DNA/chemistry
*RNA, Guide/chemistry/genetics
Streptococcus pyogenes/genetics/metabolism

@article {pmid35416602,
year = {2022},
author = {Xing, and Su, B and Li, S and Bangs, M and Creamer, D and Coogan, M and Wang, J and Simora, R and Ma, X and Hettiarachchi, D and Alston, V and Wang, W and Johnson, A and Lu, C and Hasin, T and Qin, Z and Dunham, R},
title = {CRISPR/Cas9-Mediated Transgenesis of the Masu Salmon (Oncorhynchus masou) elovl2 Gene Improves n-3 Fatty Acid Content in Channel Catfish (Ictalurus punctatus).},
journal = {Marine biotechnology (New York, N.Y.)},
volume = {24},
number = {3},
pages = {513-523},
pmid = {35416602},
issn = {1436-2236},
mesh = {Actins/genetics ; Animals ; Animals, Genetically Modified ; CRISPR-Cas Systems ; Docosahexaenoic Acids ; Eicosapentaenoic Acid ; Fatty Acids ; *Fatty Acids, Omega-3 ; Fatty Acids, Unsaturated/metabolism ; Gene Transfer Techniques ; *Ictaluridae/genetics/metabolism ; *Oncorhynchus/genetics ; Salmon/genetics ; },
abstract = {Omega-3 polyunsaturated fatty acids (n-3 PUFAs), particularly eicosapentaenoic acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3), play a very important role in human health. Channel catfish (Ictalurus punctatus) is one of the leading freshwater aquaculture species in the USA, but has low levels of EPA and DHA compared to some fish such as salmon. To improve EPA and DHA content, a modification of the n-3 PUFA biosynthetic pathway was achieved through the insertion of an elovl2 transgene isolated from masu salmon (Oncorhynchus masou) driven by a carp β-actin promoter using a two-hit by gRNA and two oligos with a targeting plasmid (2H2OP) CRISPR/Cas9 approach. Integration rate of the transgene was high (37.5%) and detected in twelve different tissues of P1 transgenic fish with tissue-specific gene expression. Liver and muscle had relative high gene expression (13.4- and 9.2-fold change, respectively). Fatty acid analysis showed DHA content in the muscle from transgenic fish was 1.62-fold higher than in non-transgenic fish (P < 0.05). Additionally, total n-3 PUFAs and omega-6 polyunsaturated fatty acids (n-6 PUFAs) increased to 1.41-fold and 1.50-fold, respectively, suggesting the β-actin-elovl2 transgene improved biosynthesis of PUFAs in channel catfish as a whole. The n-9 fatty acid level decreased in the transgenic fish compared to the control. Morphometric analysis showed that there were significant differences between injected fish with sgRNAs (including positive and negative fish) and sham-injected controls (P < 0.001). Potential off-target effects are likely the major factor responsible for morphological deformities. Optimization of sgRNA design to maximize activity and reduce off-target effects of CRISPR/Cas9 should be examined in future transgenic research, but this research shows a promising first step in the improvement of n-3 PUFAs in channel catfish.},
}

Actins/genetics
Animals
Animals, Genetically Modified
CRISPR-Cas Systems
Docosahexaenoic Acids
Eicosapentaenoic Acid
Fatty Acids
*Fatty Acids, Omega-3
Fatty Acids, Unsaturated/metabolism
Gene Transfer Techniques
*Ictaluridae/genetics/metabolism
*Oncorhynchus/genetics
Salmon/genetics

@article {pmid35394503,
year = {2022},
author = {Giordano, A and Santo Domingo, M and Quadrana, L and Pujol, M and Martín-Hernández, AM and Garcia-Mas, J},
title = {CRISPR/Cas9 gene editing uncovers the roles of CONSTITUTIVE TRIPLE RESPONSE 1 and REPRESSOR OF SILENCING 1 in melon fruit ripening and epigenetic regulation.},
journal = {Journal of experimental botany},
volume = {73},
number = {12},
pages = {4022-4033},
doi = {10.1093/jxb/erac148},
pmid = {35394503},
issn = {1460-2431},
support = {CEX2019-000902//MCIN/AEI/ ; 793090//European Union's Horizon 2020/ ; BES-2017-079956//Spanish Ministry of Economy and Competitiveness/ ; },
mesh = {CRISPR-Cas Systems ; *Cucurbitaceae/genetics ; Epigenesis, Genetic ; Ethylenes ; Fruit/genetics ; Gene Editing ; Gene Expression Regulation, Plant ; *Lycopersicon esculentum/genetics ; Plant Proteins/genetics ; Protein-Tyrosine Kinases/genetics ; Proto-Oncogene Proteins/genetics ; },
abstract = {Melon (Cucumis melo) has emerged as an alternative model to tomato for studying fruit ripening due to the coexistence of climacteric and non-climacteric varieties. Previous characterization of a major quantitative trait locus (QTL), ETHQV8.1, that is able to trigger climacteric ripening in a non-climacteric background resulted in the identification of a negative regulator of ripening CTR1-like (MELO3C024518) and a putative DNA demethylase ROS1 (MELO3C024516) that is the orthologue of DML2, a DNA demethylase that regulates fruit ripening in tomato. To understand the role of these genes in climacteric ripening, in this study we generated homozygous CRISPR knockout mutants of CTR1-like and ROS1 in a climacteric genetic background. The climacteric behavior was altered in both loss-of-function mutants in two growing seasons with an earlier ethylene production profile being observed compared to the climacteric wild type, suggesting a role of both genes in climacteric ripening in melon. Single-cytosine methylome analyses of the ROS1-knockout mutant revealed changes in DNA methylation in the promoter regions of the key ripening genes such as ACS1, ETR1, and ACO1, and in transcription factors associated with ripening including NAC-NOR, RIN, and CNR, suggesting the importance of ROS1-mediated DNA demethylation for triggering fruit ripening in melon.},
}

CRISPR-Cas Systems
*Cucurbitaceae/genetics
Epigenesis, Genetic
Ethylenes
Fruit/genetics
Gene Editing
Gene Expression Regulation, Plant
*Lycopersicon esculentum/genetics
Plant Proteins/genetics
Protein-Tyrosine Kinases/genetics
Proto-Oncogene Proteins/genetics

@article {pmid35338607,
year = {2022},
author = {Zhou, H and Wang, X and Steer, CJ and Song, G and Niu, J},
title = {Efficient silencing of hepatitis B virus S gene through CRISPR-mediated base editing.},
journal = {Hepatology communications},
volume = {6},
number = {7},
pages = {1652-1663},
doi = {10.1002/hep4.1933},
pmid = {35338607},
issn = {2471-254X},
support = {ISG-16-210-01-RMC//American Cancer Society/ ; },
mesh = {CRISPR-Cas Systems/genetics ; Codon, Nonsense ; *Hepatitis B/genetics ; Hepatitis B Surface Antigens ; *Hepatitis B virus/genetics ; Humans ; RNA, Guide/genetics ; },
abstract = {Hepatitis B virus (HBV) infection is a major risk factor of liver cirrhosis and hepatocellular carcinoma. Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) has been used to precisely edit the HBV genome and eliminate HBV through non-homologous end-joining repair of double-stranded break (DSB). However, the CRISPR/Cas9-mediated DSB triggers instability of host genome and exhibits low efficiency to edit genome, limiting its application. CRISPR cytidine base editors (CBEs) could silence genes by generating a premature stop codon. Here we developed a CRISPR base editor approach to precisely edit single nucleotide within the HBV genome to impair HBV gene expression. Specifically, a single-guide RNA (sgRNA) was designed to edit the 30th codon of HBV S gene, which encodes HBV surface antigen (HBsAg), from CAG (glutamine) to stop codon TAG. We next used human hepatoma PLC/PRF/5 cells carrying the HBV genome to establish a cell line that expresses a CBE (PLC/PRF/5-CBE). Lentivirus was used to introduce sgRNA into PLC/PRF/5-CBE cells. Phenotypically, 71% of PLC/PRF/5-CBE cells developed a premature stop codon within the S gene. Levels of HBs messenger RNA were significantly decreased. A 92% reduction of HBsAg secretion was observed in PLC/PRF/5-CBE cells. The intracellular HBsAg was also reduced by 84% after treatment of gRNA_S. Furthermore, no off-target effect was detected in predicted off-target loci within the HBV genome. Sequencing confirmed that 95%, 93%, 93%, 9%, and 72% S gene sequences of HBV genotypes B, C, F, G, and H had the binding site of sgRNA. Conclusion: Our findings indicate that CRISPR-mediated base editing is an efficient approach to silence the HBV S gene, suggesting its therapeutic potential to eliminate HBV.},
}

CRISPR-Cas Systems/genetics
Codon, Nonsense
*Hepatitis B/genetics
Hepatitis B Surface Antigens
*Hepatitis B virus/genetics
Humans
RNA, Guide/genetics

@article {pmid35757746,
year = {2022},
author = {Moretti, A and Ponzo, M and Nicolette, CA and Tcherepanova, IY and Biondi, A and Magnani, CF},
title = {The Past, Present, and Future of Non-Viral CAR T Cells.},
journal = {Frontiers in immunology},
volume = {13},
number = {},
pages = {867013},
doi = {10.3389/fimmu.2022.867013},
pmid = {35757746},
issn = {1664-3224},
abstract = {Adoptive transfer of chimeric antigen receptor (CAR) T lymphocytes is a powerful technology that has revolutionized the way we conceive immunotherapy. The impressive clinical results of complete and prolonged response in refractory and relapsed diseases have shifted the landscape of treatment for hematological malignancies, particularly those of lymphoid origin, and opens up new possibilities for the treatment of solid neoplasms. However, the widening use of cell therapy is hampered by the accessibility to viral vectors that are commonly used for T cell transfection. In the era of messenger RNA (mRNA) vaccines and CRISPR/Cas (clustered regularly interspaced short palindromic repeat-CRISPR-associated) precise genome editing, novel and virus-free methods for T cell engineering are emerging as a more versatile, flexible, and sustainable alternative for next-generation CAR T cell manufacturing. Here, we discuss how the use of non-viral vectors can address some of the limitations of the viral methods of gene transfer and allow us to deliver genetic information in a stable, effective and straightforward manner. In particular, we address the main transposon systems such as Sleeping Beauty (SB) and piggyBac (PB), the utilization of mRNA, and innovative approaches of nanotechnology like Lipid-based and Polymer-based DNA nanocarriers and nanovectors. We also describe the most relevant preclinical data that have recently led to the use of non-viral gene therapy in emerging clinical trials, and the related safety and efficacy aspects. We will also provide practical considerations for future trials to enable successful and safe cell therapy with non-viral methods for CAR T cell generation.},
}

@article {pmid35755158,
year = {2022},
author = {Whitworth, KM and Green, JA and Redel, BK and Geisert, RD and Lee, K and Telugu, BP and Wells, KD and Prather, RS},
title = {Improvements in pig agriculture through gene editing.},
journal = {CABI agriculture and bioscience},
volume = {3},
number = {1},
pages = {41},
doi = {10.1186/s43170-022-00111-9},
pmid = {35755158},
issn = {2662-4044},
abstract = {Genetic modification of animals via selective breeding is the basis for modern agriculture. The current breeding paradigm however has limitations, chief among them is the requirement for the beneficial trait to exist within the population. Desirable alleles in geographically isolated breeds, or breeds selected for a different conformation and commercial application, and more importantly animals from different genera or species cannot be introgressed into the population via selective breeding. Additionally, linkage disequilibrium results in low heritability and necessitates breeding over successive generations to fix a beneficial trait within a population. Given the need to sustainably improve animal production to feed an anticipated 9 billion global population by 2030 against a backdrop of infectious diseases and a looming threat from climate change, there is a pressing need for responsive, precise, and agile breeding strategies. The availability of genome editing tools that allow for the introduction of precise genetic modification at a single nucleotide resolution, while also facilitating large transgene integration in the target population, offers a solution. Concordant with the developments in genomic sequencing approaches, progress among germline editing efforts is expected to reach feverish pace. The current manuscript reviews past and current developments in germline engineering in pigs, and the many advantages they confer for advancing animal agriculture.},
}

@article {pmid35746591,
year = {2022},
author = {Liu, Y and Zhang, X and Chen, D and Yang, D and Zhu, C and Tang, L and Yang, X and Wang, Y and Luo, X and Wang, M and Huang, Y and Hu, Z and Liu, Z},
title = {CRISPR/Cas9-Mediated Disruption of the lef8 and lef9 to Inhibit Nucleopolyhedrovirus Replication in Silkworms.},
journal = {Viruses},
volume = {14},
number = {6},
pages = {},
doi = {10.3390/v14061119},
pmid = {35746591},
issn = {1999-4915},
support = {31830093, 32100381//The National Science Foundation of China/ ; XDB11010600//Priority Research Program of Chinese Academy of Sciences/ ; },
mesh = {Animals ; Animals, Genetically Modified ; *Bombyx ; CRISPR-Cas Systems ; *Nucleopolyhedroviruses/genetics ; },
abstract = {Bombyx mori nucleopolyhedrovirus (BmNPV) is a pathogen that causes severe disease in silkworms. In a previous study, we demonstrated that by using the CRISPR/Cas9 system to disrupt the BmNPV ie-1 and me53 genes, transgenic silkworms showed resistance to BmNPV infection. Here, we used the same strategy to simultaneously target lef8 and lef9, which are essential for BmNPV replication. A PCR assay confirmed that double-stranded breaks were induced in viral DNA at targeted sequences in BmNPV-infected transgenic silkworms that expressed small guide RNAs (sgRNAs) and Cas9. Bioassays and qPCR showed that replication of BmNPV and mortality were significantly reduced in the transgenic silkworms in comparison with the control groups. Microscopy showed degradation of midgut cells in the BmNPV-infected wild type silkworms, but not in the transgenic silkworms. These results demonstrated that transgenic silkworms using the CRISPR/Cas9 system to disrupt BmNPV lef8 and lef9 genes could successfully prevent BmNPV infection. Our research not only provides more alternative targets for the CRISPR antiviral system, but also aims to provide new ideas for the application of virus infection research and the control of insect pests.},
}

Animals
Animals, Genetically Modified
*Bombyx
CRISPR-Cas Systems
*Nucleopolyhedroviruses/genetics

@article {pmid35744944,
year = {2022},
author = {Zhang, J and Zhou, Q and Zhang, D and Yang, G and Zhang, C and Wu, Y and Xu, Y and Chen, J and Kong, W and Kong, G and Wang, J},
title = {The Agronomic Traits, Alkaloids Analysis, FT-IR and 2DCOS-IR Spectroscopy Identification of the Low-Nicotine-Content Nontransgenic Tobacco Edited by CRISPR-Cas9.},
journal = {Molecules (Basel, Switzerland)},
volume = {27},
number = {12},
pages = {},
doi = {10.3390/molecules27123817},
pmid = {35744944},
issn = {1420-3049},
support = {No. 21967021 and No. 21762050//National Natural Science Foundation of China/ ; },
mesh = {CRISPR-Cas Systems/genetics ; *Nicotine ; Spectrophotometry, Infrared ; Spectroscopy, Fourier Transform Infrared/methods ; *Tobacco/genetics ; },
abstract = {In this study, the agricultural traits, alkaloids content and Fourier transform infrared spectroscopy (FT-IR) and two-dimensional correlation infrared spectroscopy (2DCOS-IR) analysis of the tobacco after Berberine Bridge Enzyme-Like Proteins (BBLs) knockout were investigated. The knockout of BBLs has limited effect on tobacco agricultural traits. After the BBLs knockout, nicotine and most alkaloids are significantly reduced, but the content of myosmine and its derivatives increases dramatically. In order to identify the gene editing of tobacco, principal component analysis (PCA) was performed on the FT-IR and 2DCOS-IR spectroscopy data. The results showed that FT-IR can distinguish between tobacco roots and leaves but cannot classify the gene mutation tobacco from the wild one. 2DCOS-IR can enhance the characteristics of the samples due to the increased apparent resolution of the spectra. Using the autopeaks in the synchronous map for PCA analysis, we successfully identified the mutants with an accuracy of over 90%.},
}

CRISPR-Cas Systems/genetics
*Nicotine
Spectrophotometry, Infrared
Spectroscopy, Fourier Transform Infrared/methods
*Tobacco/genetics

@article {pmid35743282,
year = {2022},
author = {Chang, YJ and Kang, Z and Bei, J and Chou, SJ and Lu, MJ and Su, YL and Lin, SW and Wang, HH and Lin, S and Chang, CJ},
title = {Generation of TRIM28 Knockout K562 Cells by CRISPR/Cas9 Genome Editing and Characterization of TRIM28-Regulated Gene Expression in Cell Proliferation and Hemoglobin Beta Subunits.},
journal = {International journal of molecular sciences},
volume = {23},
number = {12},
pages = {},
doi = {10.3390/ijms23126839},
pmid = {35743282},
issn = {1422-0067},
mesh = {CRISPR-Cas Systems ; Cell Proliferation/genetics ; *Gene Editing ; Gene Expression ; Hemoglobin Subunits/genetics/metabolism ; Humans ; K562 Cells ; *MicroRNAs ; Transcription Factors/metabolism ; Tripartite Motif-Containing Protein 28/metabolism ; },
abstract = {TRIM28 is a scaffold protein that interacts with DNA-binding proteins and recruits corepressor complexes to cause gene silencing. TRIM28 contributes to physiological functions such as cell growth and differentiation. In the chronic myeloid leukemia cell line K562, we edited TRIM28 using CRISPR/Cas9 technology, and the complete and partial knockout (KO) cell clones were obtained and confirmed using quantitative droplet digital PCR (ddPCR) technology. The amplicon sequencing demonstrated no off-target effects in our gene editing experiments. The TRIM28 KO cells grew slowly and appeared red, seeming to have a tendency towards erythroid differentiation. To understand how TRIM28 controls K562 cell proliferation and differentiation, transcriptome profiling analysis was performed in wild-type and KO cells to identify TRIM28-regulated genes. Some of the RNAs that encode the proteins regulating the cell cycle were increased (such as p21) or decreased (such as cyclin D2) in TRIM28 KO cell clones; a tumor marker, the MAGE (melanoma antigen) family, which is involved in cell proliferation was reduced. Moreover, we found that knockout of TRIM28 can induce miR-874 expression to downregulate MAGEC2 mRNA via post-transcriptional regulation. The embryonic epsilon-globin gene was significantly increased in TRIM28 KO cell clones through the downregulation of transcription repressor SOX6. Taken together, we provide evidence to demonstrate the regulatory network of TRIM28-mediated cell growth and erythroid differentiation in K562 leukemia cells.},
}

CRISPR-Cas Systems
Cell Proliferation/genetics
*Gene Editing
Gene Expression
Hemoglobin Subunits/genetics/metabolism
Humans
K562 Cells
*MicroRNAs
Transcription Factors/metabolism
Tripartite Motif-Containing Protein 28/metabolism

@article {pmid35743185,
year = {2022},
author = {Voisard, P and Diofano, F and Glazier, AA and Rottbauer, W and Just, S},
title = {CRISPR/Cas9-Mediated Constitutive Loss of VCP (Valosin-Containing Protein) Impairs Proteostasis and Leads to Defective Striated Muscle Structure and Function In Vivo.},
journal = {International journal of molecular sciences},
volume = {23},
number = {12},
pages = {},
doi = {10.3390/ijms23126722},
pmid = {35743185},
issn = {1422-0067},
mesh = {Adenosine Triphosphatases/genetics/metabolism ; Animals ; CRISPR-Cas Systems ; Cell Cycle Proteins/genetics/metabolism ; *Frontotemporal Dementia/genetics/metabolism ; Muscle, Skeletal/metabolism ; *Muscle, Striated/metabolism ; Mutation ; *Myositis, Inclusion Body/genetics/metabolism ; Proteostasis/genetics ; Valosin Containing Protein/genetics/metabolism ; Zebrafish/genetics/metabolism ; },
abstract = {Valosin-containing protein (VCP) acts as a key regulator of cellular protein homeostasis by coordinating protein turnover and quality control. Mutations in VCP lead to (cardio-)myopathy and neurodegenerative diseases such as inclusion body myopathy with Paget's disease of the bone and frontotemporal dementia (IBMPFD) or amyotrophic lateral sclerosis (ALS). To date, due to embryonic lethality, no constitutive VCP knockout animal model exists. Here, we generated a constitutive CRISPR/Cas9-induced vcp knockout zebrafish model. Similar to the phenotype of vcp morphant knockdown zebrafish embryos, we found that vcp-null embryos displayed significantly impaired cardiac and skeletal muscle function. By ultrastructural analysis of skeletal muscle cells and cardiomyocytes, we observed severely disrupted myofibrillar organization and accumulation of inclusion bodies as well as mitochondrial degeneration. vcp knockout was associated with a significant accumulation of ubiquitinated proteins, suggesting impaired proteasomal function. Additionally, markers of unfolded protein response (UPR)/ER-stress and autophagy-related mTOR signaling were elevated in vcp-deficient embryos, demonstrating impaired proteostasis in VCP-null zebrafish. In conclusion, our findings demonstrate the successful generation of a stable constitutive vcp knockout zebrafish line that will enable characterization of the detailed mechanistic underpinnings of vcp loss, particularly the impact of disturbed protein homeostasis on organ development and function in vivo.},
}

Adenosine Triphosphatases/genetics/metabolism
Animals
CRISPR-Cas Systems
Cell Cycle Proteins/genetics/metabolism
*Frontotemporal Dementia/genetics/metabolism
Muscle, Skeletal/metabolism
*Muscle, Striated/metabolism
Mutation
*Myositis, Inclusion Body/genetics/metabolism
Proteostasis/genetics
Valosin Containing Protein/genetics/metabolism
Zebrafish/genetics/metabolism

@article {pmid35742919,
year = {2022},
author = {Merckx, NLL and Esch, HV},
title = {Human Brain Models of Intellectual Disability: Experimental Advances and Novelties.},
journal = {International journal of molecular sciences},
volume = {23},
number = {12},
pages = {},
doi = {10.3390/ijms23126476},
pmid = {35742919},
issn = {1422-0067},
support = {3807//International Rett syndrome Foundation/ ; },
mesh = {Brain ; CRISPR-Cas Systems ; Gene Editing ; Humans ; *Induced Pluripotent Stem Cells/metabolism ; *Intellectual Disability/genetics/metabolism/therapy ; },
abstract = {Intellectual disability (ID) is characterized by deficits in conceptual, social and practical domains. ID can be caused by both genetic defects and environmental factors and is extremely heterogeneous, which complicates the diagnosis as well as the deciphering of the underlying pathways. Multiple scientific breakthroughs during the past decades have enabled the development of novel ID models. The advent of induced pluripotent stem cells (iPSCs) enables the study of patient-derived human neurons in 2D or in 3D organoids during development. Gene-editing tools, such as CRISPR/Cas9, provide isogenic controls and opportunities to design personalized gene therapies. In practice this has contributed significantly to the understanding of ID and opened doors to identify novel therapeutic targets. Despite these advances, a number of areas of improvement remain for which novel technologies might entail a solution in the near future. The purpose of this review is to provide an overview of the existing literature on scientific breakthroughs that have been advancing the way ID can be studied in the human brain. The here described human brain models for ID have the potential to accelerate the identification of underlying pathophysiological mechanisms and the development of therapies.},
}

Brain
CRISPR-Cas Systems
Gene Editing
Humans
*Induced Pluripotent Stem Cells/metabolism
*Intellectual Disability/genetics/metabolism/therapy

@article {pmid35742831,
year = {2022},
author = {Vuelta, E and Ordoñez, JL and Sanz, DJ and Ballesteros, S and Hernández-Rivas, JM and Méndez-Sánchez, L and Sánchez-Martín, M and García-Tuñón, I},
title = {CRISPR/Cas9-Directed Gene Trap Constitutes a Selection System for Corrected BCR/ABL Leukemic Cells in CML.},
journal = {International journal of molecular sciences},
volume = {23},
number = {12},
pages = {},
doi = {10.3390/ijms23126386},
pmid = {35742831},
issn = {1422-0067},
support = {PI18/01500//Instituto de Salud Carlos III/ ; PI21/00983//Instituto de Salud Carlos III/ ; PI17/01895//Instituto de Salud Carlos III/ ; PI22/00694//Instituto de Salud Carlos III/ ; AP176752021//Fundación Mutua Madrileña/ ; SA118P20//Junta de Castilla y León/ ; Predoctoral Grant of Elena Vuelta//University of Salamanca/ ; Fundación Samuel Solórzano FS/29-2020//University of Salamanca/ ; Jabones Solidarios para Daniel//Bomberos Ayudan Fundation/ ; },
mesh = {Apoptosis/genetics ; CRISPR-Cas Systems/genetics ; Cell Proliferation/genetics ; Chronic Disease ; *Fusion Proteins, bcr-abl/genetics/metabolism ; Humans ; *Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy/therapy ; },
abstract = {Chronic myeloid leukaemia (CML) is a haematological neoplasm driven by the BCR/ABL fusion oncogene. The monogenic aspect of the disease and the feasibility of ex vivo therapies in haematological disorders make CML an excellent candidate for gene therapy strategies. The ability to abolish any coding sequence by CRISPR-Cas9 nucleases offers a powerful therapeutic opportunity to CML patients. However, a definitive cure can only be achieved when only CRISPR-edited cells are selected. A gene-trapping approach combined with CRISPR technology would be an ideal approach to ensure this. Here, we developed a CRISPR-Trap strategy that efficiently inserts a donor gene trap (SA-CMV-Venus) cassette into the BCR/ABL-specific fusion point in the CML K562 human cell line. The trapping cassette interrupts the oncogene coding sequence and expresses a reporter gene that enables the selection of edited cells. Quantitative mRNA expression analyses showed significantly higher level of expression of the BCR/Venus allele coupled with a drastically lower level of BCR/ABL expression in Venus+ cell fractions. Functional in vitro experiments showed cell proliferation arrest and apoptosis in selected Venus+ cells. Finally, xenograft experiments with the selected Venus+ cells showed a large reduction in tumour growth, thereby demonstrating a therapeutic benefit in vivo. This study represents proof of concept for the therapeutic potential of a CRISPR-Trap system as a novel strategy for gene elimination in haematological neoplasms.},
}

Apoptosis/genetics
CRISPR-Cas Systems/genetics
Cell Proliferation/genetics
Chronic Disease
*Fusion Proteins, bcr-abl/genetics/metabolism
Humans
*Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy/therapy

@article {pmid35742811,
year = {2022},
author = {Irshad, F and Li, C and Wu, HY and Yan, Y and Xu, JH},
title = {The Function of DNA Demethylase Gene ROS1a Null Mutant on Seed Development in Rice (Oryza Sativa) Using the CRISPR/CAS9 System.},
journal = {International journal of molecular sciences},
volume = {23},
number = {12},
pages = {},
doi = {10.3390/ijms23126357},
pmid = {35742811},
issn = {1422-0067},
mesh = {CRISPR-Cas Systems/genetics ; DNA/metabolism ; Endosperm/metabolism ; Gene Expression Regulation, Plant ; Glutens/metabolism ; *Oryza/metabolism ; Plant Proteins/genetics/metabolism ; Seeds/metabolism ; Starch/metabolism ; },
abstract = {The endosperm is the main nutrient source in cereals for humans, as it is a highly specialized storage organ for starch, lipids, and proteins, and plays an essential role in seed growth and development. Active DNA demethylation regulates plant developmental processes and is ensured by cytosine methylation (5-meC) DNA glycosylase enzymes. To find out the role of OsROS1a in seed development, the null mutant of OsROS1a was generated using the CRISPR/Cas9 system. The null mutant of OsROS1a was stable and heritable, which affects the major agronomic traits, particularly in rice seeds. The null mutant of OsROS1a showed longer and narrower grains, and seeds were deformed containing an underdeveloped and less-starch-producing endosperm with slightly irregularly shaped embryos. In contrast to the transparent grains of the wild type, the grains of the null mutant of OsROS1a were slightly opaque and rounded starch granules, with uneven shapes, sizes, and surfaces. A total of 723 differential expression genes (DEGs) were detected in the null mutant of OsROS1a by RNA-Seq, of which 290 were downregulated and 433 were upregulated. The gene ontology (GO) terms with the top 20 enrichment factors were visualized for cellular components, biological processes, and molecular functions. The key genes that are enriched for these GO terms include starch synthesis genes (OsSSIIa and OsSSIIIa) and cellulose synthesis genes (CESA2, CESA3, CESA6, and CESA8). Genes encoding polysaccharides and glutelin were found to be downregulated in the mutant endosperm. The glutelins were further verified by SDS-PAGE, suggesting that glutelin genes could be involved in the null mutant of OsROS1a seed phenotype and OsROS1a could have the key role in the regulation of glutelins. Furthermore, 378 differentially alternative splicing (AS) genes were identified in the null mutant of OsROS1a, suggesting that the OsROS1a gene has an impact on AS events. Our findings indicated that the function on rice endosperm development in the null mutant of OsROS1a could be influenced through regulating gene expression and AS, which could provide the base to properly understand the molecular mechanism related to the OsROS1a gene in the regulation of rice seed development.},
}

CRISPR-Cas Systems/genetics
DNA/metabolism
Endosperm/metabolism
Gene Expression Regulation, Plant
Glutens/metabolism
*Oryza/metabolism
Plant Proteins/genetics/metabolism
Seeds/metabolism
Starch/metabolism

@article {pmid35737245,
year = {2022},
author = {Sayed, S and Sürün, D and Mircetic, J and Sidorova, OA and Buchholz, F},
title = {Using CRISPR-Cas9 to Dissect Cancer Mutations in Cell Lines.},
journal = {Methods in molecular biology (Clifton, N.J.)},
volume = {2508},
number = {},
pages = {235-260},
pmid = {35737245},
issn = {1940-6029},
mesh = {*CRISPR-Cas Systems/genetics ; Cell Line ; Gene Editing ; Humans ; Mutation ; *Neoplasms/genetics ; Precision Medicine ; },
abstract = {The CRISPR-Cas9 technology has revolutionized the scope and pace of biomedical research, enabling the targeting of specific genomic sequences for a wide spectrum of applications. Here we describe assays to functionally interrogate mutations identified in cancer cells utilizing both CRISPR-Cas9 nuclease and base editors. We provide guidelines to interrogate known cancer driver mutations or functionally screen for novel vulnerability mutations with these systems in characterized human cancer cell lines. The proposed platform should be transferable to primary cancer cells, opening up a path for precision oncology on a functional level.},
}

*CRISPR-Cas Systems/genetics
Cell Line
Gene Editing
Humans
Mutation
*Neoplasms/genetics
Precision Medicine

@article {pmid35617371,
year = {2022},
author = {Schuler, G and Hu, C and Ke, A},
title = {Structural basis for RNA-guided DNA cleavage by IscB-ωRNA and mechanistic comparison with Cas9.},
journal = {Science (New York, N.Y.)},
volume = {376},
number = {6600},
pages = {1476-1481},
doi = {10.1126/science.abq7220},
pmid = {35617371},
issn = {1095-9203},
mesh = {*CRISPR-Cas Systems ; Cryoelectron Microscopy ; DNA/genetics ; *DNA Cleavage ; RNA, Bacterial/genetics ; RNA, Guide/chemistry/genetics ; },
abstract = {Class 2 CRISPR effectors Cas9 and Cas12 may have evolved from nucleases in IS200/IS605 transposons. IscB is about two-fifths the size of Cas9 but shares a similar domain organization. The associated ωRNA plays the combined role of CRISPR RNA (crRNA) and trans-activating CRISPR RNA (tracrRNA) to guide double-stranded DNA (dsDNA) cleavage. Here we report a 2.78-angstrom cryo-electron microscopy structure of IscB-ωRNA bound to a dsDNA target, revealing the architectural and mechanistic similarities between IscB and Cas9 ribonucleoproteins. Target-adjacent motif recognition, R-loop formation, and DNA cleavage mechanisms are explained at high resolution. ωRNA plays the equivalent function of REC domains in Cas9 and contacts the RNA-DNA heteroduplex. The IscB-specific PLMP domain is dispensable for RNA-guided DNA cleavage. The transition from ancestral IscB to Cas9 involved dwarfing the ωRNA and introducing protein domain replacements.},
}

*CRISPR-Cas Systems
Cryoelectron Microscopy
DNA/genetics
*DNA Cleavage
RNA, Bacterial/genetics
RNA, Guide/chemistry/genetics

@article {pmid35244715,
year = {2022},
author = {Ai, Y and Liang, D and Wilusz, JE},
title = {CRISPR/Cas13 effectors have differing extents of off-target effects that limit their utility in eukaryotic cells.},
journal = {Nucleic acids research},
volume = {50},
number = {11},
pages = {e65},
doi = {10.1093/nar/gkac159},
pmid = {35244715},
issn = {1362-4962},
support = {R35 GM119735/GM/NIGMS NIH HHS/United States ; 827222//American Heart Association/ ; R35-GM119735/NH/NIH HHS/United States ; R35-GM119735/NH/NIH HHS/United States ; },
mesh = {Animals ; *CRISPR-Cas Systems ; Drosophila/genetics ; Eukaryotic Cells ; RNA/genetics ; *RNA, Guide/genetics ; },
abstract = {CRISPR/Cas13 effectors have garnered increasing attention as easily customizable tools for detecting and depleting RNAs of interest. Near perfect complementarity between a target RNA and the Cas13-associated guide RNA is required for activation of Cas13 ribonuclease activity. Nonetheless, the specificity of Cas13 effectors in eukaryotic cells has been debated as the Cas13 nuclease domains can be exposed on the enzyme surface, providing the potential for promiscuous cleavage of nearby RNAs (so-called collateral damage). Here, using co-transfection assays in Drosophila and human cells, we found that the off-target effects of RxCas13d, a commonly used Cas13 effector, can be as strong as the level of on-target RNA knockdown. The extent of off-target effects is positively correlated with target RNA expression levels, and collateral damage can be observed even after reducing RxCas13d/guide RNA levels. The PspCas13b effector showed improved specificity and, unlike RxCas13d, can be used to deplete a Drosophila circular RNA without affecting the expression of the associated linear RNA. PspCas13b nonetheless still can have off-target effects and we notably found that the extent of off-target effects for Cas13 effectors differs depending on the cell type and target RNA examined. In total, these results highlight the need for caution when designing and interpreting Cas13-based knockdown experiments.},
}

Animals
*CRISPR-Cas Systems
Drosophila/genetics
Eukaryotic Cells
RNA/genetics
*RNA, Guide/genetics

@article {pmid35212386,
year = {2022},
author = {Zhao, Z and Shang, P and Sage, F and Geijsen, N},
title = {Ligation-assisted homologous recombination enables precise genome editing by deploying both MMEJ and HDR.},
journal = {Nucleic acids research},
volume = {50},
number = {11},
pages = {e62},
doi = {10.1093/nar/gkac118},
pmid = {35212386},
issn = {1362-4962},
support = {//China Scholarship Council/ ; //H2020 iPSpine/ ; },
mesh = {*CRISPR-Cas Systems/genetics ; DNA Breaks, Double-Stranded ; DNA End-Joining Repair/genetics ; *Gene Editing ; Homologous Recombination/genetics ; Recombinational DNA Repair ; },
abstract = {CRISPR/Cas12a is a single effector nuclease that, like CRISPR/Cas9, has been harnessed for genome editing based on its ability to generate targeted DNA double strand breaks (DSBs). Unlike the blunt-ended DSB generated by Cas9, Cas12a generates sticky-ended DSB that could potentially aid precise genome editing, but this unique feature has thus far been underutilized. In the current study, we found that a short double-stranded DNA (dsDNA) repair template containing a sticky end that matched one of the Cas12a-generated DSB ends and a homologous arm sharing homology with the genomic region adjacent to the other end of the DSB enabled precise repair of the DSB and introduced a desired nucleotide substitution. We termed this strategy 'Ligation-Assisted Homologous Recombination' (LAHR). Compared to the single-stranded oligo deoxyribonucleotide (ssODN)-mediated homology directed repair (HDR), LAHR yields relatively high editing efficiency as demonstrated for both a reporter gene and endogenous genes. We found that both HDR and microhomology-mediated end joining (MMEJ) mechanisms are involved in the LAHR process. Our LAHR genome editing strategy, extends the repertoire of genome editing technologies and provides a broader understanding of the type and role of DNA repair mechanisms involved in genome editing.},
}

*CRISPR-Cas Systems/genetics
DNA Breaks, Double-Stranded
DNA End-Joining Repair/genetics
*Gene Editing
Homologous Recombination/genetics
Recombinational DNA Repair

@article {pmid35752768,
year = {2022},
author = {Guo, G and Wang, Z and Li, Q and Yu, Y and Li, Y and Tan, Z and Zhang, W},
title = {Genomic characterization of Streptococcus parasuis, a close relative of Streptococcus suis and also a potential opportunistic zoonotic pathogen.},
journal = {BMC genomics},
volume = {23},
number = {1},
pages = {469},
pmid = {35752768},
issn = {1471-2164},
support = {KYCX21_0643//Postgraduate Research & Practice Innovation Program of Jiangsu Province/ ; ZD2021037//Key scientific research project of Jiangsu Commission of Health/ ; 31772751//National Natural Science Foundation of China/ ; NAUSY-MS12//Guidance Foundation, the Sanya Institute of Nanjing Agricultural University/ ; },
abstract = {Streptococcus parasuis (S. parasuis) is a close relative of Streptococcus suis (S. suis), composed of former members of S. suis serotypes 20, 22 and 26. S. parasuis could infect pigs and cows, and recently, human infection cases have been reported, making S. parasuis a potential opportunistic zoonotic pathogen. In this study, we analysed the genomic characteristics of S. parasuis, using pan-genome analysis, and compare some phenotypic determinants such as capsular polysaccharide, integrative conjugative elements, CRISPR-Cas system and pili, and predicted the potential virulence genes by associated analysis of the clinical condition of isolated source animals and genotypes. Furthermore, to discuss the relationship with S. suis, we compared these characteristics of S. parasuis with those of S. suis. We found that the characteristics of S. parasuis are similar to those of S. suis, both of them have "open" pan-genome, their antimicrobial resistance gene profiles are similar and a srtF pilus cluster of S. suis was identified in S. parasuis genome. But S. parasuis still have its unique characteristics, two novel pilus clusters are and three different type CRISPR-Cas system were found. Therefore, this study provides novel insights into the interspecific and intraspecific genetic characteristics of S. parasuis, which can be useful for further study of this opportunistic pathogen, such as serotyping, diagnostics, vaccine development, and study of the pathogenesis mechanism.},
}

@article {pmid35752617,
year = {2022},
author = {de Freitas Almeida, GM and Hoikkala, V and Ravantti, J and Rantanen, N and Sundberg, LR},
title = {Mucin induces CRISPR-Cas defense in an opportunistic pathogen.},
journal = {Nature communications},
volume = {13},
number = {1},
pages = {3653},
pmid = {35752617},
issn = {2041-1723},
support = {314939//Academy of Finland (Suomen Akatemia)/ ; },
abstract = {Parasitism by bacteriophages has led to the evolution of a variety of defense mechanisms in their host bacteria. However, it is unclear what factors lead to specific defenses being deployed upon phage infection. To explore this question, we co-evolved the bacterial fish pathogen Flavobacterium columnare and its virulent phage V156 in presence and absence of a eukaryotic host signal (mucin) for sixteen weeks. The presence of mucin leads to a dramatic increase in CRISPR spacer acquisition, especially in low nutrient conditions where over 60% of colonies obtain at least one new spacer. Additionally, we show that the presence of a competitor bacterium further increases CRISPR spacer acquisition in F. columnare. These results suggest that ecological factors are important in determining defense strategies against phages, and that the phage-bacterium interactions on mucosal surfaces may select for the diversification of bacterial immune systems.},
}

@article {pmid35752612,
year = {2022},
author = {Qin, S and Xiao, W and Zhou, C and Pu, Q and Deng, X and Lan, L and Liang, H and Song, X and Wu, M},
title = {Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics.},
journal = {Signal transduction and targeted therapy},
volume = {7},
number = {1},
pages = {199},
pmid = {35752612},
issn = {2059-3635},
support = {R01 AI138203-3//Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.)/ ; },
abstract = {Pseudomonas aeruginosa (P. aeruginosa) is a Gram-negative opportunistic pathogen that infects patients with cystic fibrosis, burn wounds, immunodeficiency, chronic obstructive pulmonary disorder (COPD), cancer, and severe infection requiring ventilation, such as COVID-19. P. aeruginosa is also a widely-used model bacterium for all biological areas. In addition to continued, intense efforts in understanding bacterial pathogenesis of P. aeruginosa including virulence factors (LPS, quorum sensing, two-component systems, 6 type secretion systems, outer membrane vesicles (OMVs), CRISPR-Cas and their regulation), rapid progress has been made in further studying host-pathogen interaction, particularly host immune networks involving autophagy, inflammasome, non-coding RNAs, cGAS, etc. Furthermore, numerous technologic advances, such as bioinformatics, metabolomics, scRNA-seq, nanoparticles, drug screening, and phage therapy, have been used to improve our understanding of P. aeruginosa pathogenesis and host defense. Nevertheless, much remains to be uncovered about interactions between P. aeruginosa and host immune responses, including mechanisms of drug resistance by known or unannotated bacterial virulence factors as well as mammalian cell signaling pathways. The widespread use of antibiotics and the slow development of effective antimicrobials present daunting challenges and necessitate new theoretical and practical platforms to screen and develop mechanism-tested novel drugs to treat intractable infections, especially those caused by multi-drug resistance strains. Benefited from has advancing in research tools and technology, dissecting this pathogen's feature has entered into molecular and mechanistic details as well as dynamic and holistic views. Herein, we comprehensively review the progress and discuss the current status of P. aeruginosa biophysical traits, behaviors, virulence factors, invasive regulators, and host defense patterns against its infection, which point out new directions for future investigation and add to the design of novel and/or alternative therapeutics to combat this clinically significant pathogen.},
}

@article {pmid35751797,
year = {2022},
author = {Sirohi, U and Kumar, M and Sharma, VR and Teotia, S and Singh, D and Chaudhary, V and Priya, and Yadav, MK},
title = {CRISPR/Cas9 System: A Potential Tool for Genetic Improvement in Floricultural Crops.},
journal = {Molecular biotechnology},
volume = {},
number = {},
pages = {},
pmid = {35751797},
issn = {1559-0305},
abstract = {Demand of flowers is increasing with time worldwide. Floriculture has become one of the most important commercial trades in agriculture. Although traditional breeding methods like hybridization and mutation breeding have contributed significantly to the development of important flower varieties, flower production and quality of flowers can be significantly improved by employing modern breeding approaches. Novel traits of significance have interest to consumers and producers, such as fragrance, new floral color, change in floral architecture and morphology, vase life, aroma, and resistance to biotic and abiotic stresses, have been introduced by genetic manipulation. The clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein (Cas) system has recently emerged as a powerful genome-editing tool for accurately changing DNA sequences at specific locations. It provides excellent means of genetically improving floricultural crops. CRISPR/Cas system has been utilized in gene editing in horticultural cops. There are few reports on the utilization of the CRISPR/Cas9 system in flowers. The current review summarizes the research work done by employing the CRISPR/Cas9 system in floricultural crops including improvement in flowering traits such as color modification, prolonging the shelf life of flowers, flower initiation, and development, changes in color of ornamental foliage by genome editing. CRISPR/Cas9 gene editing could be useful in developing novel cultivars with higher fragrance and enhanced essential oil and many other useful traits. The present review also highlights the basic mechanism and key components involved in the CRISPR/Cas9 system.},
}

@article {pmid35751791,
year = {2022},
author = {Datta, A and Sarmah, D and Kaur, H and Chaudhary, A and Vadak, N and Borah, A and Shah, S and Wang, X and Bhattacharya, P},
title = {Advancement in CRISPR/Cas9 Technology to Better Understand and Treat Neurological Disorders.},
journal = {Cellular and molecular neurobiology},
volume = {},
number = {},
pages = {},
pmid = {35751791},
issn = {1573-6830},
support = {45/13/2020-PHA/BMS//Indian Council of Medical Research/ ; 34/5/2019-TF/Nano/BMS//Indian Council of Medical Research/ ; },
abstract = {Neurological disorders have complicated pathophysiology that may involve several genetic mutations. Conventional treatment has limitations as they only treat apparent symptoms. Although, personalized medicine is emerging as a promising neuro-intervention, lack of precision is the major pitfall. Clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 system is evolving as a technological platform that may overcome the therapeutic limitations towards precision medicine. In the future, targeting genes in neurological disorders may be the mainstay of modern therapy. The present review on CRISPR/Cas9 and its application in various neurological disorders may provide a platform for its future clinical relevance towards developing precise and personalized medicine.},
}

@article {pmid35751329,
year = {2022},
author = {Khan, SH and Zaidi, SK and Gilani, M},
title = {PCR to CRISPR: Role of Nucleic Acid Tests (NAT) in detection of COVID-19.},
journal = {JPMA. The Journal of the Pakistan Medical Association},
volume = {72},
number = {6},
pages = {1166-1174},
doi = {10.47391/JPMA.2324},
pmid = {35751329},
issn = {0030-9982},
abstract = {COVID-19 infection has emerged as an unparalleled pandemic with morbidity and mortality tolls challenging diagnostic approaches and therapeutic interventions, and raising serious questions for healthcare policy-makers. From the diagnostic perspective, Reverse transcriptase polymerase chain reaction remains the gold standard. However, issues associated with gene primer variation in different countries, low analytical sensitivity, cross-reactivity with certain human coronaviruses have raised serious concerns within the scientific community. Alongside longer turnaround times, requirements of sophisticated equipment and trained technicians are the other challenges for conventional reverse transcriptase polymerase chain reaction testing. The recent biotechnological boom has now allowed newer nucleic acid testing options for diagnosing severe acute respiratory syndrome Coronovairus 2 (SARS-CoV2) with much better diagnostic efficiency, reduced turnaround times and possible benefit for use as a point-of-care test. Isothermal techniques with simple equipment requirements along with uniform temperature for analysis have emerged to be more sensitive and specific with turnaround times as low as 10-15 minutes. Similarly, Cluster Regularly Interspaced Short Palindromic Repeats have also been seen to play a very decisive role in COVID-19 diagnostics with much superior diagnostic efficiency and feasibility as a point-of-care test and its possible use for sequencing. The current narrative review was planned to consolidate data for all possible nucleic acid testing options under research/clinical use, and to provide a comparative assessment from the perspective of both the clinician and the laboratory.},
}

@article {pmid35750651,
year = {2022},
author = {Hillary, VE and Ceasar, SA},
title = {Prime editing in plants and mammalian cells: Mechanism, achievements, limitations, and future prospects.},
journal = {BioEssays : news and reviews in molecular, cellular and developmental biology},
volume = {},
number = {},
pages = {e2200032},
doi = {10.1002/bies.202200032},
pmid = {35750651},
issn = {1521-1878},
abstract = {Clustered, regularly interspaced, short palindromic repeat (CRISPR)/CRISPR-associated protein (CRISPR/Cas) system has revolutionized genetic research in the life sciences. Four classes of CRISPR/Cas-derived genome editing agents, such as nuclease, base editor, recombinase, and prime editor have been introduced for engineering the genomes of diverse organisms. The recently introduced prime editing system offers precise editing without many off-target effects than traditional CRISPR-based systems. Many researchers have successfully applied this gene-editing toolbox in diverse systems for various genome-editing applications. This review presents the mechanism of prime editing and summarizes the details of the prime editing system applied in plants and mammalian cells for precise genome editing. We also discuss the advantages, limitations, and potential future applications of prime editing in these systems. This review enables the researcher to gain knowledge on prime editing tools and their potential applications in plants and mammalian cells.},
}

@article {pmid35748558,
year = {2022},
author = {Mohammad-Rafiei, F and Safdarian, E and Adel, B and Vandchali, NR and Navashenaq, JG and Gheibihayat, SM},
title = {CRISPR: A Promising Tool for Cancer Therapy.},
journal = {Current molecular medicine},
volume = {},
number = {},
pages = {},
doi = {10.2174/1566524022666220624111311},
pmid = {35748558},
issn = {1875-5666},
abstract = {The clustered regularly interspaced short palindromic repeats system, called CRISPR, as one of the major technological advances, allows geneticists and researchers to perform genome editing. This remarkable technology is quickly eclipsing zinc-finger nucleases (ZFNs) and other editing tools, and its ease of use and accuracy have thus far revolutionized genome editing, from fundamental science projects to medical research and treatment options. This system consists of two key components: a CRISPR-associated (Cas) nuclease, which binds and cuts deoxyribonucleic acid (DNA) and a guide ribonucleic acid (gRNA) sequence, directing the Cas nuclease to its target site. In the research arena, CRISPR has been up to now exploited in various ways alongside gene editing, such as epigenome modifications, genome-wide screening, targeted cancer therapies, and so on. This article reviews the current perceptions of the CRISPR/Cas systems with special attention to studies reflecting on the relationship between the CRISPR/Cas systems and their role in cancer therapy.},
}

@article {pmid35743007,
year = {2022},
author = {Thomson, MJ and Biswas, S and Tsakirpaloglou, N and Septiningsih, EM},
title = {Functional Allele Validation by Gene Editing to Leverage the Wealth of Genetic Resources for Crop Improvement.},
journal = {International journal of molecular sciences},
volume = {23},
number = {12},
pages = {},
doi = {10.3390/ijms23126565},
pmid = {35743007},
issn = {1422-0067},
support = {2017-67013-26194; 2022-67013-36210; 2020-67013-31811//United States Department of Agriculture/ ; NA//Texas A&M AgriLife Research/ ; NA//Texas A&M University X-Grant/ ; },
abstract = {Advances in molecular technologies over the past few decades, such as high-throughput DNA marker genotyping, have provided more powerful plant breeding approaches, including marker-assisted selection and genomic selection. At the same time, massive investments in plant genetics and genomics, led by whole genome sequencing, have led to greater knowledge of genes and genetic pathways across plant genomes. However, there remains a gap between approaches focused on forward genetics, which start with a phenotype to map a mutant locus or QTL with the goal of cloning the causal gene, and approaches using reverse genetics, which start with large-scale sequence data and work back to the gene function. The recent establishment of efficient CRISPR-Cas-based gene editing promises to bridge this gap and provide a rapid method to functionally validate genes and alleles identified through studies of natural variation. CRISPR-Cas techniques can be used to knock out single or multiple genes, precisely modify genes through base and prime editing, and replace alleles. Moreover, technologies such as protoplast isolation, in planta transformation, and the use of developmental regulatory genes promise to enable high-throughput gene editing to accelerate crop improvement.},
}

@article {pmid35741761,
year = {2022},
author = {Wang, HQ and Wang, T and Gao, F and Ren, WZ},
title = {Application of CRISPR/Cas Technology in Spermatogenesis Research and Male Infertility Treatment.},
journal = {Genes},
volume = {13},
number = {6},
pages = {},
doi = {10.3390/genes13061000},
pmid = {35741761},
issn = {2073-4425},
support = {31972570//National Natural Science Foundation of China/ ; },
abstract = {As the basis of animal reproductive activity, normal spermatogenesis directly determines the efficiency of livestock production. An in-depth understanding of spermatogenesis will greatly facilitate animal breeding efforts and male infertility treatment. With the continuous development and application of gene editing technologies, they have become valuable tools to study the mechanism of spermatogenesis. Gene editing technologies have provided us with a better understanding of the functions and potential mechanisms of action of factors that regulate spermatogenesis. This review summarizes the applications of gene editing technologies, especially CRISPR/Cas9, in deepening our understanding of the function of spermatogenesis-related genes and disease treatment. The problems of gene editing technologies in the field of spermatogenesis research are also discussed.},
}

@article {pmid35741243,
year = {2022},
author = {Hernandez-Garcia, A and Morales-Moreno, MD and Valdés-Galindo, EG and Jimenez-Nieto, EP and Quezada, A},
title = {Diagnostics of COVID-19 Based on CRISPR-Cas Coupled to Isothermal Amplification: A Comparative Analysis and Update.},
journal = {Diagnostics (Basel, Switzerland)},
volume = {12},
number = {6},
pages = {},
doi = {10.3390/diagnostics12061434},
pmid = {35741243},
issn = {2075-4418},
support = {proyectos de investigación y desarrollo para hacer frente a la COVID-19//AMEXCID/ ; IV200820//DGAPA-PAPIIT/ ; },
abstract = {The emergence of the COVID-19 pandemic prompted fast development of novel diagnostic methods of the etiologic virus SARS-CoV-2. Methods based on CRISPR-Cas systems have been particularly promising because they can achieve a similar sensitivity and specificity to the benchmark RT-qPCR, especially when coupled to an isothermal pre-amplification step. Furthermore, they have also solved inherent limitations of RT-qPCR that impede its decentralized use and deployment in the field, such as the need for expensive equipment, high cost per reaction, and delivery of results in hours, among others. In this review, we evaluate publicly available methods to detect SARS-CoV-2 that are based on CRISPR-Cas and isothermal amplification. We critically analyze the steps required to obtain a successful result from clinical samples and pinpoint key experimental conditions and parameters that could be optimized or modified to improve clinical and analytical outputs. The COVID outbreak has propelled intensive research in a short time, which is paving the way to develop effective and very promising CRISPR-Cas systems for the precise detection of SARS-CoV-2. This review could also serve as an introductory guide to new labs delving into this technology.},
}

@article {pmid35741144,
year = {2022},
author = {Selvam, K and Ahmad Najib, M and Khalid, MF and Ozsoz, M and Aziah, I},
title = {CRISPR-Cas Systems-Based Bacterial Detection: A Scoping Review.},
journal = {Diagnostics (Basel, Switzerland)},
volume = {12},
number = {6},
pages = {},
doi = {10.3390/diagnostics12061335},
pmid = {35741144},
issn = {2075-4418},
support = {311/CIPPM/4401005//Higher Institution Centre of Excellence (HICoE), Ministry of Higher Education, Malaysia/ ; },
abstract = {Recently, CRISPR-Cas system-based assays for bacterial detection have been developed. The aim of this scoping review is to map existing evidence on the utilization of CRISPR-Cas systems in the development of bacterial detection assays. A literature search was conducted using three databases (PubMed, Scopus, and Cochrane Library) and manual searches through the references of identified full texts based on a PROSPERO-registered protocol (CRD42021289140). Studies on bacterial detection using CRISPR-Cas systems that were published before October 2021 were retrieved. The Critical Appraisal Skills Programme (CASP) qualitative checklist was used to assess the risk of bias for all the included studies. Of the 420 studies identified throughout the search, 46 studies that met the inclusion criteria were included in the final analysis. Bacteria from 17 genera were identified utilising CRISPR-Cas systems. Most of the bacteria came from genera such as Staphylococcus, Escherichia, Salmonella, Listeria, Mycobacterium and Streptococcus. Cas12a (64%) is the most often used Cas enzyme in bacterial detection, followed by Cas13a (13%), and Cas9 (11%). To improve the signal of detection, 83% of the research exploited Cas enzymes' trans-cleavage capabilities to cut tagged reporter probes non-specifically. Most studies used the extraction procedure, whereas only 17% did not. In terms of amplification methods, isothermal reactions were employed in 66% of the studies, followed by PCR (23%). Fluorescence detection (67%) was discovered to be the most commonly used method, while lateral flow biosensors (13%), electrochemical biosensors (11%), and others (9%) were found to be less commonly used. Most of the studies (39) used specific bacterial nucleic acid sequences as a target, while seven used non-nucleic acid targets, including aptamers and antibodies particular to the bacteria under investigation. The turnaround time of the 46 studies was 30 min to 4 h. The limit of detection (LoD) was evaluated in three types of concentration, which include copies per mL, CFU per mL and molarity. Most of the studies used spiked samples (78%) rather than clinical samples (22%) to determine LoD. This review identified the gap in clinical accuracy evaluation of the CRISPR-Cas system in bacterial detection. More research is needed to assess the diagnostic sensitivity and specificity of amplification-free CRISPR-Cas systems in bacterial detection for nucleic acid-based tests.},
}

@article {pmid35739111,
year = {2022},
author = {Lainšček, D and Forstnerič, V and Mikolič, V and Malenšek, Š and Pečan, P and Benčina, M and Sever, M and Podgornik, H and Jerala, R},
title = {Coiled-coil heterodimer-based recruitment of an exonuclease to CRISPR/Cas for enhanced gene editing.},
journal = {Nature communications},
volume = {13},
number = {1},
pages = {3604},
pmid = {35739111},
issn = {2041-1723},
support = {P4-0176//Javna Agencija za Raziskovalno Dejavnost RS (Slovenian Research Agency)/ ; },
abstract = {The CRISPR/Cas system has emerged as a powerful and versatile genome engineering tool, revolutionizing biological and biomedical sciences, where an improvement of efficiency could have a strong impact. Here we present a strategy to enhance gene editing based on the concerted action of Cas9 and an exonuclease. Non-covalent recruitment of exonuclease to Cas9/gRNA complex via genetically encoded coiled-coil based domains, termed CCExo, recruited the exonuclease to the cleavage site and robustly increased gene knock-out due to progressive DNA strand recession at the cleavage site, causing decreased re-ligation of the nonedited DNA. CCExo exhibited increased deletion size and enhanced gene inactivation efficiency in the context of several DNA targets, gRNA selection, Cas variants, tested cell lines and type of delivery. Targeting a sequence-specific oncogenic chromosomal translocation using CCExo in cells of chronic myelogenous leukemia patients and in an animal model led to the reduction or elimination of cancer, establishing it as a highly specific tool for treating CML and potentially other appropriate diseases with genetic etiology.},
}

@article {pmid35551512,
year = {2022},
author = {Lei, Z and Meng, H and Liu, L and Zhao, H and Rao, X and Yan, Y and Wu, H and Liu, M and He, A and Yi, C},
title = {Mitochondrial base editor induces substantial nuclear off-target mutations.},
journal = {Nature},
volume = {606},
number = {7915},
pages = {804-811},
pmid = {35551512},
issn = {1476-4687},
mesh = {CRISPR-Cas Systems ; *Cytosine/metabolism ; DNA, Mitochondrial/genetics ; *Gene Editing/methods ; Mitochondria/genetics/metabolism ; Mutation ; },
abstract = {DddA-derived cytosine base editors (DdCBEs)-which are fusions of split DddA halves and transcription activator-like effector (TALE) array proteins from bacteria-enable targeted C•G-to-T•A conversions in mitochondrial DNA1. However, their genome-wide specificity is poorly understood. Here we show that the mitochondrial base editor induces extensive off-target editing in the nuclear genome. Genome-wide, unbiased analysis of its editome reveals hundreds of off-target sites that are TALE array sequence (TAS)-dependent or TAS-independent. TAS-dependent off-target sites in the nuclear DNA are often specified by only one of the two TALE repeats, challenging the principle that DdCBEs are guided by paired TALE proteins positioned in close proximity. TAS-independent off-target sites on nuclear DNA are frequently shared among DdCBEs with distinct TALE arrays. Notably, they co-localize strongly with binding sites for the transcription factor CTCF and are enriched in topologically associating domain boundaries. We engineered DdCBE to alleviate such off-target effects. Collectively, our results have implications for the use of DdCBEs in basic research and therapeutic applications, and suggest the need to thoroughly define and evaluate the off-target effects of base-editing tools.},
}

CRISPR-Cas Systems
*Cytosine/metabolism
DNA, Mitochondrial/genetics
*Gene Editing/methods
Mitochondria/genetics/metabolism
Mutation

@article {pmid35736067,
year = {2022},
author = {Devanna, BN and Jain, P and Solanke, AU and Das, A and Thakur, S and Singh, PK and Kumari, M and Dubey, H and Jaswal, R and Pawar, D and Kapoor, R and Singh, J and Arora, K and Saklani, BK and AnilKumar, C and Maganti, SM and Sonah, H and Deshmukh, R and Rathour, R and Sharma, TR},
title = {Understanding the Dynamics of Blast Resistance in Rice-Magnaporthe oryzae Interactions.},
journal = {Journal of fungi (Basel, Switzerland)},
volume = {8},
number = {6},
pages = {},
doi = {10.3390/jof8060584},
pmid = {35736067},
issn = {2309-608X},
support = {NA//Department of Science and Technology/ ; },
abstract = {Rice is a global food grain crop for more than one-third of the human population and a source for food and nutritional security. Rice production is subjected to various stresses; blast disease caused by Magnaporthe oryzae is one of the major biotic stresses that has the potential to destroy total crop under severe conditions. In the present review, we discuss the importance of rice and blast disease in the present and future global context, genomics and molecular biology of blast pathogen and rice, and the molecular interplay between rice-M. oryzae interaction governed by different gene interaction models. We also elaborated in detail on M. oryzae effector and Avr genes, and the role of noncoding RNAs in disease development. Further, rice blast resistance QTLs; resistance (R) genes; and alleles identified, cloned, and characterized are discussed. We also discuss the utilization of QTLs and R genes for blast resistance through conventional breeding and transgenic approaches. Finally, we review the demonstrated examples and potential applications of the latest genome-editing tools in understanding and managing blast disease in rice.},
}

@article {pmid35735623,
year = {2022},
author = {Li, X and Xu, S and Fuhrmann-Aoyagi, MB and Yuan, S and Iwama, T and Kobayashi, M and Miura, K},
title = {CRISPR/Cas9 Technique for Temperature, Drought, and Salinity Stress Responses.},
journal = {Current issues in molecular biology},
volume = {44},
number = {6},
pages = {2664-2682},
doi = {10.3390/cimb44060182},
pmid = {35735623},
issn = {1467-3045},
support = {JPMJOP1851//Japan Science and Technology Agency/ ; },
abstract = {Global warming and climate change have severely affected plant growth and food production. Therefore, minimizing these effects is required for sustainable crop yields. Understanding the molecular mechanisms in response to abiotic stresses and improving agricultural traits to make crops tolerant to abiotic stresses have been going on unceasingly. To generate desirable varieties of crops, traditional and molecular breeding techniques have been tried, but both approaches are time-consuming. Clustered regularly interspaced short palindromic repeat/Cas9 (CRISPR/Cas9) and transcription activator-like effector nucleases (TALENs) are genome-editing technologies that have recently attracted the attention of plant breeders for genetic modification. These technologies are powerful tools in the basic and applied sciences for understanding gene function, as well as in the field of crop breeding. In this review, we focus on the application of genome-editing systems in plants to understand gene function in response to abiotic stresses and to improve tolerance to abiotic stresses, such as temperature, drought, and salinity stresses.},
}

@article {pmid35732990,
year = {2022},
author = {Kobelt, D and Pahle, J and Walther, W},
title = {A Brief Introduction to Current Cancer Gene Therapy.},
journal = {Methods in molecular biology (Clifton, N.J.)},
volume = {2521},
number = {},
pages = {1-21},
pmid = {35732990},
issn = {1940-6029},
abstract = {Gene therapy has started in the late 1980s as novel, clinically applicable therapeutic option. It revolutionized the treatment of genetic diseases with the initial intent to repair or replace defective genes. Gene therapy has been adapted for treatment of malignant diseases to improve the outcome of cancer patients. In fact, cancer gene therapy has rapidly gained great interest and evolved into a research field with highest proportion of research activities in gene therapy. In this context, cancer gene therapy has long entered translation into clinical trials and therefore more than two-thirds of all gene therapy trials worldwide are aiming at the treatment of cancer disease using different therapeutic strategies. During the decades in cancer gene therapy, tremendous knowledge has accumulated. This led to significant improvements in vector design, transgene repertoire, more targeted interventions, use of novel gene therapeutic technologies such as CRISPR/Cas, sleeping beauty vectors, and development of effective cancer immunogene therapies. In this chapter, a brief overview of current key developments in cancer gene therapy is provided to gain insights into the recent directions in research as well as in clinical application of cancer gene therapy.},
}

@article {pmid35727982,
year = {2022},
author = {Hu, M and Qiu, Z and Bi, Z and Tian, T and Jiang, Y and Zhou, X},
title = {Photocontrolled crRNA activation enables robust CRISPR-Cas12a diagnostics.},
journal = {Proceedings of the National Academy of Sciences of the United States of America},
volume = {119},
number = {26},
pages = {e2202034119},
doi = {10.1073/pnas.2202034119},
pmid = {35727982},
issn = {1091-6490},
support = {32150019//National Natural Science Foundation of China (NSFC)/ ; 91959128//National Natural Science Foundation of China (NSFC)/ ; 21874049//National Natural Science Foundation of China (NSFC)/ ; 2020BCA090//The Key Research and Development Plan of Hubei Province/ ; 2021A1515220164//GDSTC | Basic and Applied Basic Research Foundation of Guangdong Province ()/ ; },
mesh = {*COVID-19 ; CRISPR-Cas Systems/genetics ; Humans ; Nucleic Acid Amplification Techniques/methods ; RNA ; Recombinases/genetics ; *SARS-CoV-2/genetics ; Sensitivity and Specificity ; },
abstract = {CRISPR diagnostics based on nucleic acid amplification faces barriers to its commercial use, such as contamination risks and insufficient sensitivity. Here, we propose a robust solution involving optochemical control of CRISPR RNA (crRNA) activation in CRISPR detection. Based on this strategy, recombinase polymerase amplification (RPA) and CRISPR-Cas12a detection systems can be integrated into a completely closed test tube. crRNA can be designed to be temporarily inactivated so that RPA is not affected by Cas12a cleavage. After the RPA reaction is completed, the CRISPR-Cas12a detection system is activated under rapid light irradiation. This photocontrolled, fully closed CRISPR diagnostic system avoids contamination risks and exhibits a more than two orders of magnitude improvement in sensitivity compared with the conventional one-pot assay. This photocontrolled CRISPR method was applied to the clinical detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA, achieving detection sensitivity and specificity comparable to those of PCR. Furthermore, a compact and automatic photocontrolled CRISPR detection device was constructed.},
}

*COVID-19
CRISPR-Cas Systems/genetics
Humans
Nucleic Acid Amplification Techniques/methods
RNA
Recombinases/genetics
*SARS-CoV-2/genetics
Sensitivity and Specificity

@article {pmid35727555,
year = {2022},
author = {Ametrano, A and Coscia, MR},
title = {Production of a Chimeric Mouse-Fish Monoclonal Antibody by the CRISPR/Cas9 Technology.},
journal = {Methods in molecular biology (Clifton, N.J.)},
volume = {2498},
number = {},
pages = {337-350},
pmid = {35727555},
issn = {1940-6029},
mesh = {Animals ; Antibodies, Monoclonal/genetics/metabolism ; *CRISPR-Cas Systems/genetics ; Fishes/metabolism ; *Gene Editing/methods ; Hybridomas/metabolism ; Mice ; RNA, Guide/genetics ; Technology ; },
abstract = {The CRISPR/Cas9 system, a defense mechanism naturally occurring in prokaryotes, has been recently repurposed as an RNA-guided DNA targeting platform and widely used as a powerful tool for genome editing. Here we describe how to modify the carboxy-terminal region, called Fragment crystallizable (Fc) region, of a murine monoclonal antibody by replacing the heavy chain constant exons with those from a teleost fish antibody by the CRISPR/Cas9 system. We outline optimal conditions for knockout and knockin mechanisms to edit the Immunoglobulin heavy chain (IgH) constant region gene locus in a murine hybridoma cell line. A chimeric mouse-fish monoclonal antibody can be successfully produced by hybridoma cell lines engineered according to this protocol.},
}

Animals
Antibodies, Monoclonal/genetics/metabolism
*CRISPR-Cas Systems/genetics
Fishes/metabolism
*Gene Editing/methods
Hybridomas/metabolism
Mice
RNA, Guide/genetics
Technology

@article {pmid35727554,
year = {2022},
author = {Russo, MT and Santin, A and Rogato, A and Ferrante, MI},
title = {Optimized Proteolistic Protocol for the Delivery of the Cas9 Protein in Phaeodactylum tricornutum.},
journal = {Methods in molecular biology (Clifton, N.J.)},
volume = {2498},
number = {},
pages = {327-336},
pmid = {35727554},
issn = {1940-6029},
mesh = {Biolistics/methods ; *CRISPR-Associated Protein 9/genetics ; CRISPR-Cas Systems ; Cell Nucleus/genetics ; *Diatoms/genetics ; },
abstract = {The CRISPR/Cas9 system coupled with proteolistics is a DNA-free nuclear transformation method based on the introduction of ribonucleoprotein (RNP) complexes into cells. The method has been set up for diatoms as an alternative to genetic transformation via biolistics and has the advantages of reducing off-target mutations, limiting the working time of the Cas9 endonuclease, and overcoming the occurrence of random insertions of the transgene in the genome. We present a point-by-point description of the protocol with modifications that make it more cost-effective, by reducing the amount of the enzyme while maintaining a comparable efficiency to the original protocol, and with an increased concentration of the selective drug which allows to reduce false positives.},
}

Biolistics/methods
*CRISPR-Associated Protein 9/genetics
CRISPR-Cas Systems
Cell Nucleus/genetics
*Diatoms/genetics

@article {pmid35727450,
year = {2022},
author = {Chen, W and She, W and Li, A and Zhai, C and Ma, L},
title = {Site-Directed Mutagenesis Method Mediated by Cas9.},
journal = {Methods in molecular biology (Clifton, N.J.)},
volume = {2461},
number = {},
pages = {165-174},
pmid = {35727450},
issn = {1940-6029},
mesh = {*CRISPR-Cas Systems ; *Escherichia coli/genetics ; Mutagenesis ; Mutagenesis, Site-Directed ; Plasmids/genetics ; Polymerase Chain Reaction ; },
abstract = {This study presents an in vitro CRISPR/Cas9-mediated mutagenic (ICM) system that allows rapid construction of designed mutants or site-saturation mutagenesis libraries in a PCR-independent manner. The plasmid DNA is double digested with Cas9 bearing specific single guide RNAs to remove the target nucleotides. Next, T5 exonuclease excises both 5'-ends of the linearized plasmid to generate homologous regions of approximately 15 nt. Subsequently, a short dsDNA of approximately 30-50 bp containing the desired mutation cyclizes the plasmid through base pairing and introduces the mutation into the plasmid. The gaps are repaired in Escherichia coli host cells after transformation. This method is highly efficient and accurate. Both single and multiple site-directed mutagenesis can be successfully performed, especially to large sized plasmids. This method demonstrates the great potential for creating high-quality mutant libraries in directed evolution as an alternative to PCR-based saturation mutagenesis, thus facilitating research on synthetic biology.},
}

*CRISPR-Cas Systems
*Escherichia coli/genetics
Mutagenesis
Mutagenesis, Site-Directed
Plasmids/genetics
Polymerase Chain Reaction

@article {pmid35695482,
year = {2022},
author = {Zhang, RX and Li, BB and Yang, ZG and Huang, JQ and Sun, WH and Bhanbhro, N and Liu, WT and Chen, KM},
title = {Dissecting Plant Gene Functions Using CRISPR Toolsets for Crop Improvement.},
journal = {Journal of agricultural and food chemistry},
volume = {70},
number = {24},
pages = {7343-7359},
doi = {10.1021/acs.jafc.2c01754},
pmid = {35695482},
issn = {1520-5118},
mesh = {*CRISPR-Cas Systems ; Crops, Agricultural/genetics ; Gene Editing ; *Genes, Plant ; Genome, Plant ; Plant Breeding ; },
abstract = {The CRISPR-based gene editing technology has become more and more powerful in genome manipulation for agricultural breeding, with numerous improved toolsets springing up. In recent years, many CRISPR toolsets for gene editing, such as base editors (BEs), CRISPR interference (CRISPRi), CRISPR activation (CRISPRa), and plant epigenetic editors (PEEs), have been developed to clarify gene function and full-level gene regulation. Here, we comprehensively summarize the application and capacity of the different CRISPR toolsets in the study of plant gene expression regulation, highlighting their potential application in gene regulatory networks' analysis. The general problems in CRISPR application and the optimal solutions in the existing schemes for high-throughput gene function analysis are also discussed. The CRISPR toolsets targeting gene manipulation discussed here provide new solutions for further genetic improvement and molecular breeding of crops.},
}

*CRISPR-Cas Systems
Crops, Agricultural/genetics
Gene Editing
*Genes, Plant
Genome, Plant
Plant Breeding

@article {pmid33945142,
year = {2022},
author = {Thongsin, N and Wattanapanitch, M},
title = {CRISPR/Cas9 Ribonucleoprotein Complex-Mediated Efficient B2M Knockout in Human Induced Pluripotent Stem Cells (iPSCs).},
journal = {Methods in molecular biology (Clifton, N.J.)},
volume = {2454},
number = {},
pages = {607-624},
pmid = {33945142},
issn = {1940-6029},
mesh = {CRISPR-Cas Systems ; Gene Editing ; HLA Antigens/genetics ; Histocompatibility Antigens Class I/metabolism ; Humans ; *Induced Pluripotent Stem Cells ; Ribonucleoproteins/metabolism ; },
abstract = {Advances in induced pluripotent stem cell (iPSC) technology provide a renewable source of cells for tissue regeneration and therefore hold great promise for cell replacement therapy. However, immune rejection of allograft due to human leukocyte antigen (HLA) mismatching remains a major challenge. Considerable efforts have been devoted to overcoming the immunogenicity of allograft transplantation. One of the approaches is an elimination of HLA molecules on the surface of allogeneic cells using genome editing technology to generate universal stem cells. Here, we present a simple and effective genome editing approach to knockout the β-2-immunoglobulin (B2M) gene, which encodes B2M protein that forms a heterodimer with HLA class I proteins, in induced pluripotent stem cells (iPSCs) leading to HLA class I (HLA-I) depletion. We also describe detailed procedures for validation of the B2M-knockout iPSCs using flow cytometry, and genotypic analysis for potential off-target regions. Our protocol is also applicable for knocking out other genes in iPSCs and other cell types.},
}

CRISPR-Cas Systems
Gene Editing
HLA Antigens/genetics
Histocompatibility Antigens Class I/metabolism
Humans
*Induced Pluripotent Stem Cells
Ribonucleoproteins/metabolism

@article {pmid33834266,
year = {2022},
author = {Kratzer, K and Getz, LJ and Peterlini, T and Masson, JY and Dellaire, G},
title = {Addressing the dark matter of gene therapy: technical and ethical barriers to clinical application.},
journal = {Human genetics},
volume = {141},
number = {6},
pages = {1175-1193},
pmid = {33834266},
issn = {1432-1203},
support = {PJT-156017/CAPMC/CIHR/Canada ; PJT-156017/CAPMC/CIHR/Canada ; },
mesh = {*CRISPR-Cas Systems ; *Gene Editing/methods ; Genetic Therapy/methods ; Germ Cells ; Humans ; },
abstract = {Gene therapies for genetic diseases have been sought for decades, and the relatively recent development of the CRISPR/Cas9 gene-editing system has encouraged a new wave of interest in the field. There have nonetheless been significant setbacks to gene therapy, including unintended biological consequences, ethical scandals, and death. The major focus of research has been on technological problems such as delivery, potential immune responses, and both on and off-target effects in an effort to avoid negative clinical outcomes. While the field has concentrated on how we can better achieve gene therapies and gene editing techniques, there has been less focus on when and why we should use such technology. Here we combine discussion of both the technical and ethical barriers to the widespread clinical application of gene therapy and gene editing, providing a resource for gene therapy experts and novices alike. We discuss ethical problems and solutions, using cystic fibrosis and beta-thalassemia as case studies where gene therapy might be suitable, and provide examples of situations where human germline gene editing may be ethically permissible. Using such examples, we propose criteria to guide researchers and clinicians in deciding whether or not to pursue gene therapy as a treatment. Finally, we summarize how current progress in the field adheres to principles of biomedical ethics and highlight how this approach might fall short of ethical rigour using examples in the bioethics literature. Ultimately by addressing both the technical and ethical aspects of gene therapy and editing, new frameworks can be developed for the fair application of these potentially life-saving treatments.},
}

*CRISPR-Cas Systems
*Gene Editing/methods
Genetic Therapy/methods
Germ Cells
Humans

@article {pmid33830454,
year = {2022},
author = {Thamodaran, V and Rani, S and Velayudhan, SR},
title = {Gene Editing in Human Induced Pluripotent Stem Cells Using Doxycycline-Inducible CRISPR-Cas9 System.},
journal = {Methods in molecular biology (Clifton, N.J.)},
volume = {2454},
number = {},
pages = {755-773},
pmid = {33830454},
issn = {1940-6029},
support = {IA/S/17/1/503118/WTDBT_/DBT-Wellcome Trust India Alliance/India ; },
mesh = {CRISPR-Cas Systems/genetics ; Doxycycline/pharmacology ; *Gene Editing/methods ; Humans ; *Induced Pluripotent Stem Cells/metabolism ; RNA, Guide/genetics/metabolism ; },
abstract = {Induced pluripotent stem cells (iPSCs) generated from patients are a valuable tool for disease modelling, drug screening, and studying the functions of cell/tissue-specific genes. However, for this research, isogenic iPSC lines are important for comparison of phenotypes in the wild type and mutant differentiated cells generated from the iPSCs. The advent of gene editing technologies to correct or generate mutations helps in the generation of isogenic iPSC lines with the same genetic background. Due to the ease of programming, CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)-Cas9-based gene editing tools have gained pace in gene manipulation studies, including investigating complex diseases like cancer. An iPSC line with drug inducible Cas9 expression from the Adeno-Associated Virus Integration Site 1 (AAVS1) safe harbor locus offers a controllable expression of Cas9 with robust gene editing. Here, we describe a stepwise protocol for the generation and characterization of such an iPSC line (AAVS1-PDi-Cas9 iPSC) with a doxycycline (dox)-inducible Cas9 expression cassette from the AAVS1 safe harbor site and efficient editing of target genes with lentiviral vectors expressing gRNAs. This approach with a tunable Cas9 expression that allows investigating gene functions in iPSCs or in the differentiated cells can serve as a versatile tool in disease modelling studies.},
}

CRISPR-Cas Systems/genetics
Doxycycline/pharmacology
*Gene Editing/methods
Humans
*Induced Pluripotent Stem Cells/metabolism
RNA, Guide/genetics/metabolism

@article {pmid33755904,
year = {2022},
author = {Brandão, KO and Grandela, C and Yiangou, L and Mummery, CL and Davis, RP},
title = {CRISPR/Cas9-Mediated Introduction of Specific Heterozygous Mutations in Human Induced Pluripotent Stem Cells.},
journal = {Methods in molecular biology (Clifton, N.J.)},
volume = {2454},
number = {},
pages = {531-557},
pmid = {33755904},
issn = {1940-6029},
support = {638030/ERC_/European Research Council/International ; },
mesh = {CRISPR-Cas Systems/genetics ; Gene Editing/methods ; Humans ; *Induced Pluripotent Stem Cells/metabolism ; Mutation ; RNA, Guide/genetics/metabolism ; },
abstract = {Advances in genome editing and our ability to derive and differentiate human induced pluripotent stem cells (hiPSCs) into a wide variety of cell types present in the body is revolutionizing how we model human diseases in vitro. Central to this has been the development of the CRISPR/Cas9 system as an inexpensive and highly efficient tool for introducing or correcting disease-associated mutations. However, the ease with which CRISPR/Cas9 enables genetic modification is a double-edged sword, with the challenge now being to introduce changes precisely to just one allele without disrupting the other.In this chapter, we describe strategies to introduce specific mutations into hiPSCs without enrichment steps. Monoallelic modification is contingent on the target activity of the guide RNA, delivery method of the CRISPR/Cas9 components and design of the oligonucleotide(s) transfected. As well as addressing these aspects, we detail high throughput culturing, freezing and screening methods to identify clonal hiPSCs with the desired nucleotide change. This set of protocols offers an efficient and ultimately time- and labor-saving approach for generating isogenic pairs of hiPSCs to detect subtle phenotypic differences caused by the disease variant.},
}

CRISPR-Cas Systems/genetics
Gene Editing/methods
Humans
*Induced Pluripotent Stem Cells/metabolism
Mutation
RNA, Guide/genetics/metabolism

@article {pmid33755901,
year = {2022},
author = {Sanjurjo-Soriano, C and Erkilic, N and Mamaeva, D and Kalatzis, V},
title = {CRISPR/Cas9-Mediated Genome Editing to Generate Clonal iPSC Lines.},
journal = {Methods in molecular biology (Clifton, N.J.)},
volume = {2454},
number = {},
pages = {589-606},
pmid = {33755901},
issn = {1940-6029},
mesh = {Animals ; CRISPR-Cas Systems/genetics ; Cells, Cultured ; *Gene Editing/methods ; Humans ; *Induced Pluripotent Stem Cells/metabolism ; Mammals/genetics ; },
abstract = {The ability to reprogram somatic cells into induced pluripotent stem cells (iPSCs) was developed in 2006 and represented a major breakthrough in stem cell research. A more recent milestone in biomedical research was reached in 2013 when the CRISPR/Cas9 system was used to edit the genome of mammalian cells. The coupling of both human (h)iPSCs and CRISPR/Cas9 technology offers great promise for cell therapy and regenerative medicine. However, several limitations including time and labor consumption, efficiency and efficacy of the system, and the potential off-targets effects induced by the Cas9 nuclease still need to be addressed. Here, we describe a detailed method for easily engineering genetic changes in hiPSCs, using a nucleofection-mediated protocol to deliver the CRISPR/Cas9 components into the cells, and discuss key points to be considered when designing your experiment. The clonal, genome-edited hiPSC line generated via our method can be directly used for downstream applications.},
}

Animals
CRISPR-Cas Systems/genetics
Cells, Cultured
*Gene Editing/methods
Humans
*Induced Pluripotent Stem Cells/metabolism
Mammals/genetics

@article {pmid33750926,
year = {2022},
author = {Chen, Y and Wen, R and Yang, Z and Chen, Z},
title = {Genome editing using CRISPR/Cas9 to treat hereditary hematological disorders.},
journal = {Gene therapy},
volume = {29},
number = {5},
pages = {207-216},
pmid = {33750926},
issn = {1476-5462},
support = {81971886//National Natural Science Foundation of China (National Science Foundation of China)/ ; },
mesh = {CRISPR-Associated Protein 9/genetics ; CRISPR-Cas Systems ; *Gene Editing/methods ; *Hematologic Diseases/genetics/therapy ; Humans ; RNA, Guide/genetics ; },
abstract = {The clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 (CRISPR/Cas9) system is a versatile and convenient genome-editing tool with prospects in gene therapy. This technique is based on customized site-specific nucleases with programmable guiding RNAs that cleave and introduce double-strand breaks (DSBs) at the target locus and achieve precise genome modification by triggering DNA repair mechanisms. Human hematopoietic stem/progenitor cells (HSPCs) are conventional cell targets for gene therapy in hematological diseases and have been widely used in most studies. Induced pluripotent stem cells (iPSCs) can be generated from a variety of somatic cells and hold great promise for personalized cell-based therapies. CRISPR/Cas9-mediated genome editing in autologous HSPCs and iPSCs is an ideal therapeutic solution for treating hereditary hematological disorders. Here, we review and summarize the latest studies about CRISPR/Cas9-mediated genome editing in patient-derived HSPCs and iPSCs to treat hereditary hematological disorders. Current challenges and prospects are also discussed.},
}

CRISPR-Associated Protein 9/genetics
CRISPR-Cas Systems
*Gene Editing/methods
*Hematologic Diseases/genetics/therapy
Humans
RNA, Guide/genetics

@article {pmid35725215,
year = {2022},
author = {Khademi, Z and Ramezani, M and Alibolandi, M and Zirak, MR and Salmasi, Z and Abnous, K and Taghdisi, SM},
title = {A novel dual-targeting delivery system for specific delivery of CRISPR/Cas9 using hyaluronic acid, chitosan and AS1411.},
journal = {Carbohydrate polymers},
volume = {292},
number = {},
pages = {119691},
doi = {10.1016/j.carbpol.2022.119691},
pmid = {35725215},
issn = {1879-1344},
mesh = {Aptamers, Nucleotide ; *CRISPR-Cas Systems/genetics ; *Chitosan ; Gene Transfer Techniques ; HEK293 Cells ; Humans ; Hyaluronic Acid ; Oligodeoxyribonucleotides ; },
abstract = {A facile method was designed that can specifically deliver CRISPR/Cas9 into target cells nuclei and reduce the off-target effects. A multifunctional delivery vector for FOXM1 knockout was composed by integration of cell targeting polymer (hyaluronic acid) and cell and nuclear targeting group (AS1411 aptamer) on the surface of nanoparticles formed by genome editing plasmid and chitosan (CS) as the core (Apt-HA-CS-CRISPR/Cas9). The data of cytotoxicity experiment and western blot confirmed this issue. The results of flow cytometry analysis and fluorescence imaging demonstrated that Apt-HA-CS-CRISPR/Cas9 was significantly internalized into target cells (MCF-7, SK-MES-1, HeLa) but not into nontarget cells (HEK293). Furthermore, the in vivo studies displayed that the Apt-HA-CS-CRISPR/Cas9 was strongly rendered tumor inhibitory effect and delivered efficiently CRISPR/Cas9 into the tumor with no detectable distribution in other organs compared with naked plasmid. This approach provides an avenue for specific in vivo gene editing therapeutics with the lowest side effect.},
}

Aptamers, Nucleotide
*CRISPR-Cas Systems/genetics
*Chitosan
Gene Transfer Techniques
HEK293 Cells
Humans
Hyaluronic Acid
Oligodeoxyribonucleotides

@article {pmid35723482,
year = {2022},
author = {Rathbone, T and Ates, I and Stuart, C and Parker, T and Cottle, RN},
title = {Electroporation-mediated Delivery of Cas9 Ribonucleoproteins and mRNA into Freshly Isolated Primary Mouse Hepatocytes.},
journal = {Journal of visualized experiments : JoVE},
volume = {},
number = {184},
pages = {},
doi = {10.3791/63828},
pmid = {35723482},
issn = {1940-087X},
mesh = {Animals ; *CRISPR-Cas Systems ; Electroporation/methods ; Hepatocytes/metabolism ; Mice ; RNA, Messenger/genetics ; *Ribonucleoproteins/genetics/metabolism ; },
abstract = {This protocol describes a fast and effective method for isolating primary mouse hepatocytes followed by electroporation-mediated delivery of CRISPR-Cas9 as ribonucleoproteins (RNPs) and mRNA. Primary mouse hepatocytes were isolated using a three-step retrograde perfusion method resulting in high yields of up to 50 × 106 cells per liver and cell viability of >85%. This protocol provides detailed instructions for plating, staining, and culturing hepatocytes. The results indicate that electroporation provides a high transfection efficiency of 89%, as measured by the percentage of green fluorescent protein (GFP)-positive cells and modest cell viability of >35% in mouse hepatocytes. To demonstrate the utility of this approach, CRISPR-Cas9 targeting the hydroxyphenylpyruvate dioxygenase gene was electroporated into primary mouse hepatocytes as proof-of-principle gene editing to disrupt a therapeutic gene related to an inherited metabolic disease (IMD) of the liver. A higher on-target edit of 78% was observed for RNPs compared to 47% editing efficiency with mRNA. The functionality of hepatocytes was evaluated in vitro using an albumin assay that indicated that delivering CRISPR-Cas9 as RNPs and mRNA results in comparable cell viability in primary mouse hepatocytes. A promising application for this protocol is the generation of mouse models for human genetic diseases affecting the liver.},
}

Animals
*CRISPR-Cas Systems
Electroporation/methods
Hepatocytes/metabolism
Mice
RNA, Messenger/genetics
*Ribonucleoproteins/genetics/metabolism

@article {pmid35687910,
year = {2022},
author = {Zuo, Q and Xu, W and Wan, Y and Feng, D and He, C and Lin, C and Huang, D and Chen, F and Han, L and Sun, Q and Chen, D and Du, H and Huang, L},
title = {Efficient generation of a CYP3A4-T2A-luciferase knock-in HepaRG subclone and its optimized differentiation.},
journal = {Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie},
volume = {152},
number = {},
pages = {113243},
doi = {10.1016/j.biopha.2022.113243},
pmid = {35687910},
issn = {1950-6007},
mesh = {*CRISPR-Cas Systems/genetics ; *Cytochrome P-450 CYP3A/genetics ; Gene Editing/methods ; Gene Knock-In Techniques ; Luciferases/genetics ; },
abstract = {CRISPR/Cas9 has allowed development of better and easier-to-use ADME models than traditional methods by complete knockout or knock-in of genes. However, gene editing in HepaRG cells remains challenging because long-term monoclonal cultivation may alter their differentiation capacity to a large extent. Here, CRISPR/Cas9 was used to generate a CYP3A4-T2A-luciferase knock-in HepaRG subclone by Cas9-mediated homologous recombination and monoclonal cultivation. The knock-in HepaRG-#9 subclone retained a similar differentiation potential to wildtype HepaRG cells (HepaRG-WT). To further improve differentiation and expand the applications of knock-in HepaRG cells, two optimized differentiation procedures were evaluated by comparison with the standard differentiation procedure using the knock-in HepaRG-#9 subclone and HepaRG-WT. The results indicated that addition of forskolin (an adenylate cyclase activator) and SB431542 (a TGF-β pathway inhibitor) to the first optimized differentiation procedure led to better differentiation consequence in terms of not only the initiation time for differentiation and morphological characterization, but also the mRNA levels of hepatocyte-specific genes. These data may contribute to more extensive applications of genetically modified HepaRG cells in ADME studies.},
}

*CRISPR-Cas Systems/genetics
*Cytochrome P-450 CYP3A/genetics
Gene Editing/methods
Gene Knock-In Techniques
Luciferases/genetics

@article {pmid35670376,
year = {2022},
author = {Zhang, W and Shi, R and Dong, K and Hu, H and Shu, W and Mu, Y and Yan, B and Li, L and Xiao, X and Wang, H},
title = {The Off-Target Effect of CRISPR-Cas12a System toward Insertions and Deletions between Target DNA and crRNA Sequences.},
journal = {Analytical chemistry},
volume = {94},
number = {24},
pages = {8596-8604},
doi = {10.1021/acs.analchem.1c05499},
pmid = {35670376},
issn = {1520-6882},
mesh = {*CRISPR-Cas Systems/genetics ; DNA/genetics ; *Gene Editing/methods ; Mutation ; RNA/genetics ; },
abstract = {The CRISPR-Cas12a system is a new type of genome editing tool with high efficiency and targeting. However, other sequences in the genome may also be cleaved nonspecifically, resulting in unavoidable off-target effects. Therefore, it is necessary to learn more about the mechanism of CRISPR-Cas12a to recognize target sequences to avoid its off-target effects. Here, we show that insertion (DNA bubble) or deletion (RNA bubble) of the target dsDNA sequence compared with the crRNA sequence, the CRISPR-Cas12a system can still recognize and cleave the target dsDNA sequence. We conclude that the tolerance of CRISPR-Cas12a to the bubbles is closely related to the location and size of the bubble and the GC base content of crRNA. In addition, we used the unique property of CRISPR-Cas12a to invent a new method to detect mutations and successfully detect the CD41-42(-CTTT) mutation. The detection limit of this method is 0.001%. Overall, our results strongly indicate that in addition to considering off-target effects caused by base mismatches, a comprehensive off-target analysis of the insertion and deletion of the target dsDNA sequence is required, and specific guidelines for effectively reducing potential off-target cleavage are proposed, to improve the safety manual of CRISPR-Cas12a biological application.},
}

*CRISPR-Cas Systems/genetics
DNA/genetics
*Gene Editing/methods
Mutation
RNA/genetics

@article {pmid35666940,
year = {2022},
author = {Hou, Y and Wang, D and Lu, S and Guo, D and Li, M and Cui, M and Zhang, XE},
title = {Optogenetic Control of Background Fluorescence Reduction for CRISPR-Based Genome Imaging.},
journal = {Analytical chemistry},
volume = {94},
number = {24},
pages = {8724-8731},
doi = {10.1021/acs.analchem.2c01113},
pmid = {35666940},
issn = {1520-6882},
mesh = {*CRISPR-Cas Systems/genetics ; Cell Nucleus ; Genome ; Microscopy, Fluorescence ; *Optogenetics ; },
abstract = {The CRISPR/dCas9 system has become an essential tool for live-cell imaging of genomic loci, but it has limited applications in imaging low-/non-repetitive genomic loci due to the strong nuclear background noise emerging from many untargeted fluorescent modules. Here, we propose an optogenetically controlled background fluorescence reduction strategy that combines the CRISPR-SunTag system with a light-inducible nuclear export tag (LEXY). Utilizing the SunTag system, multiple copies of LEXY-tagged sfGFP were recruited to the C-terminal dCas9, recognizing the target genomic loci. As the nuclear export sequence at the C-terminal LEXY could be exposed to pulsed blue light irradiation, the untargeted nuclear labeling modules were light controllably transferred to the cytoplasm. Consequently, genomic loci containing as few as nine copies of repeats were clearly visualized, and a significant increase in the signal-to-noise ratio was achieved. This simple and controllable method is expected to have a wide range of applications in cell biology.},
}

*CRISPR-Cas Systems/genetics
Cell Nucleus
Genome
Microscopy, Fluorescence
*Optogenetics

@article {pmid35169967,
year = {2022},
author = {Widjaya, MA and Ju, JC and Lee, SD},
title = {CRISPR-Edited Stem Cell Transplantation for HIV-Related Gene Modification In Vivo: A Systematic Review.},
journal = {Stem cell reviews and reports},
volume = {18},
number = {5},
pages = {1743-1755},
pmid = {35169967},
issn = {2629-3277},
mesh = {CRISPR-Cas Systems/genetics ; Gene Editing/methods ; *HIV Infections/genetics/therapy ; *Hematopoietic Stem Cell Transplantation ; Humans ; Stem Cell Transplantation ; },
abstract = {BACKGROUND: CRISPR is a novel genomic editing technology which can be useful for the treatment of immune diseases such as HIV. However, the application of CRISPR in stem cells for HIV-related research was not effective, and most of the research was done in vivo. This systematic review is to identify a new research idea about increase CRISPR-editing efficiencies in stem cell transplantation for HIV treatment, as well as its future perspective.

METHOD: Four databases were searched for articles published during 1952 to 2020. PRISMA method was used to select appropriate research papers. CAMARADES was used to identify the paper quality. The outcome was engraftment efficiency, gene disruption percentage, differentiation ability, HIV-resistant efficiency.

RESULT: Screening method showed 196 papers mentioned the topic. However, only 5 studies were reliable with the research objective. We found that (1) Two research ideas which was double gene knockout and knockout-knockin method to provide HIV-resistant cells, engraftment support and avoid cardiac disease as an HIV disease side effect. (2) Ribonucleoprotein (RNP) delivery was the best way to deliver the CRISPR/Cas9 and Adeno-Associated Virus (AAV) would be effective for knockin purpose. (3) CRISPR/SaCas9 could replace CRISPR/Cas9 role in editing HIV-related gene.

CONCLUSION: Potential genes to increase HIV resistance and stem cell engraftment should be explored more in the future. Double knockout and knock-in procedures should be applied to set up a better engraftment for improving HIV treatment or resistance of patients. CRISPR/SaCas9 and RNP delivery should be explored more in the future.

PROSPERO CRD42020203312.},
}

CRISPR-Cas Systems/genetics
Gene Editing/methods
*HIV Infections/genetics/therapy
*Hematopoietic Stem Cell Transplantation
Humans
Stem Cell Transplantation

@article {pmid35089463,
year = {2022},
author = {Fu, J and Fu, YW and Zhao, JJ and Yang, ZX and Li, SA and Li, GH and Quan, ZJ and Zhang, F and Zhang, JP and Zhang, XB and Sun, CK},
title = {Improved and Flexible HDR Editing by Targeting Introns in iPSCs.},
journal = {Stem cell reviews and reports},
volume = {18},
number = {5},
pages = {1822-1833},
pmid = {35089463},
issn = {2629-3277},
mesh = {*CRISPR-Cas Systems/genetics ; DNA End-Joining Repair/genetics ; Introns/genetics ; Pyridazines ; Quinazolines ; *Recombinational DNA Repair ; },
abstract = {Highly efficient gene knockout (KO) editing of CRISPR-Cas9 has been achieved in iPSCs, whereas homology-directed repair (HDR)-mediated precise gene knock-in (KI) and high-level expression are still bottlenecks for the clinical applications of iPSCs. Here, we developed a novel editing strategy that targets introns. By targeting the intron before the stop codon, this approach tolerates reading frameshift mutations caused by nonhomologous end-joining (NHEJ)-mediated indels, thereby maintaining gene integrity without damaging the non-HDR-edited allele. Furthermore, to increase the flexibility and screen for the best intron-targeting sgRNA, we designed an HDR donor with an artificial intron in place of the endogenous intron. The presence of artificial introns, particularly an intron that carries an enhancer element, significantly increased the reporter expression levels in iPSCs compared to the intron-deleted control. In addition, a combination of the small molecules M3814 and trichostatin A (TSA) significantly improves HDR efficiency by inhibiting NHEJ. These results should find applications in gene therapy and basic research, such as creating reporter cell lines.},
}

*CRISPR-Cas Systems/genetics
DNA End-Joining Repair/genetics
Introns/genetics
Pyridazines
Quinazolines
*Recombinational DNA Repair

@article {pmid34112918,
year = {2022},
author = {Fan, W and Yu, M and Wang, X and Xie, W and Tian, R and Cui, Z and Jin, Z and Huang, Z and Das, BC and Severinov, K and Hitzeroth, II and Debata, PR and Tian, X and Xie, H and Lang, B and Tan, J and Xu, H and Hu, Z},
title = {Non-homologous dsODN increases the mutagenic effects of CRISPR-Cas9 to disrupt oncogene E7 in HPV positive cells.},
journal = {Cancer gene therapy},
volume = {29},
number = {6},
pages = {758-769},
pmid = {34112918},
issn = {1476-5500},
mesh = {CRISPR-Cas Systems/genetics ; Female ; Humans ; Mutagens ; Oligodeoxyribonucleotides ; Oncogenes ; *Papillomavirus Infections/genetics ; *Uterine Cervical Neoplasms/genetics/therapy ; },
abstract = {Genome editing tools targeting high-risk human papillomavirus (HPV) oncogene could be a promising therapeutic strategy for the treatment of HPV-related cervical cancer. We aimed to improve the editing efficiency and detect off-target effects concurrently for the clinical translation strategy by using CRISPR-Cas9 system co-transfected with 34nt non-homologous double-stranded oligodeoxynucleotide (dsODN). We firstly tested this strategy on targeting the Green Fluorescent Protein (GFP) gene, of which the expression is easily observed. Our results showed that the GFP+ cells were significantly decreased when using GFP-sgRNAs with dsODN, compared to using GFP-sgRNAs without donors. By PCR and Sanger sequencing, we verified the dsODN integration into the break sites of the GFP gene. And by amplicon sequencing, we observed that the indels% of the targeted site on the GFP gene was increased by using GFP-sgRNAs with dsODN. Next, we went on to target the HPV18 E7 oncogene by using single E7-sgRNA and multiplexed E7-sgRNAs respectively. Whenever using single sgRNA or multiplexed sgRNAs, the mRNA expression of HPV18 E7 oncogene was significantly decreased when adding E7-sgRNAs with dsODN, compared to E7-sgRNAs without donor. And the indels% of the targeted sites on the HPV18 E7 gene was markedly increased by adding dsODN with E7-sgRNAs. Finally, we performed GUIDE-Seq to verify that the integrated dsODN could serve as the marker to detect off-target effects in using single or multiplexed two sgRNAs. And we detected fewer on-target reads and off-target sites in multiplexes compared to the single sgRNAs when targeting the GFP and the HPV18 E7 genes. Together, CRISPR-Cas9 system co-transfected with 34nt dsODN concurrently improved the editing efficiency and monitored off-target effects, which might provide new insights in the treatment of HPV infections and related cervical cancer.},
}

CRISPR-Cas Systems/genetics
Female
Humans
Mutagens
Oligodeoxyribonucleotides
Oncogenes
*Papillomavirus Infections/genetics
*Uterine Cervical Neoplasms/genetics/therapy

@article {pmid35727866,
year = {2022},
author = {Lee, YY and Park, R and Miller, SM and Li, Y},
title = {Genetic compensation of triacylglycerol biosynthesis in the green microalga Chlamydomonas reinhardtii.},
journal = {The Plant journal : for cell and molecular biology},
volume = {},
number = {},
pages = {},
doi = {10.1111/tpj.15874},
pmid = {35727866},
issn = {1365-313X},
abstract = {Genetic compensation has been proposed to explain phenotypic differences between gene knockouts and knockdowns in several metazoan and plant model systems. With the rapid development of reverse genetic tools such as CRISPR/Cas9 and RNAi in microalgae, it is increasingly important to assess whether genetic compensation affects the phenotype of engineered algal mutants. While exploring triacylglycerol (TAG) biosynthesis pathways in the model alga Chlamydomonas reinhardtii, it was discovered that knockout of certain genes catalyzing rate-limiting steps of TAG biosynthesis, type-2 diacylglycerol acyltransferase genes (DGTTs), triggered genetic compensation under abiotic stress conditions. Genetic compensation of a DGTT1 null mutation by a related PDAT gene was observed regardless of the strain background or mutagenesis approach, e.g., CRISPR/Cas 9 or insertional mutagenesis. However, no compensation was found in the PDAT knockout mutant. The effect of PDAT knockout was evaluated in a Δvtc1 mutant, in which PDAT was up-regulated under stress, resulting in a 90% increase in TAG content. Knockout of PDAT in the Δvtc1 background induced a 12.8-fold upregulation of DGTT1 and a 272.3% increase in TAG content in Δvtc1/pdat1 cells, while remaining viable. These data suggest that genetic compensation contributes to the genetic robustness of microalgal TAG biosynthetic pathways, maintaining lipid and redox homeostasis in the knockout mutants under abiotic stress. This work demonstrates examples of genetic compensation in microalgae, implies the physiological relevance of genetic compensation in TAG biosynthesis under stress, and provides guidance for future genetic engineering and mutant characterization efforts.},
}

@article {pmid35715750,
year = {2022},
author = {Vaghari-Tabari, M and Hassanpour, P and Sadeghsoltani, F and Malakoti, F and Alemi, F and Qujeq, D and Asemi, Z and Yousefi, B},
title = {CRISPR/Cas9 gene editing: a new approach for overcoming drug resistance in cancer.},
journal = {Cellular & molecular biology letters},
volume = {27},
number = {1},
pages = {49},
pmid = {35715750},
issn = {1689-1392},
mesh = {CRISPR-Cas Systems/genetics ; Drug Resistance ; *Gene Editing/methods ; Humans ; *Neoplasms/drug therapy/genetics ; RNA ; },
abstract = {The CRISPR/Cas9 system is an RNA-based adaptive immune system in bacteria and archaea. Various studies have shown that it is possible to target a wide range of human genes and treat some human diseases, including cancers, by the CRISPR/Cas9 system. In fact, CRISPR/Cas9 gene editing is one of the most efficient genome manipulation techniques. Studies have shown that CRISPR/Cas9 technology, in addition to having the potential to be used as a new therapeutic approach in the treatment of cancers, can also be used to enhance the effectiveness of existing treatments. Undoubtedly, the issue of drug resistance is one of the main obstacles in the treatment of cancers. Cancer cells resist anticancer drugs by a variety of mechanisms, such as enhancing anticancer drugs efflux, enhancing DNA repair, enhancing stemness, and attenuating apoptosis. Mutations in some proteins of different cellular signaling pathways are associated with these events and drug resistance. Recent studies have shown that the CRISPR/Cas9 technique can be used to target important genes involved in these mechanisms, thereby increasing the effectiveness of anticancer drugs. In this review article, studies related to the applications of this technique in overcoming drug resistance in cancer cells will be reviewed. In addition, we will give a brief overview of the limitations of the CRISP/Cas9 gene-editing technique.},
}

CRISPR-Cas Systems/genetics
Drug Resistance
*Gene Editing/methods
Humans
*Neoplasms/drug therapy/genetics
RNA

@article {pmid35724001,
year = {2022},
author = {Montano Gomez, P},
title = {.},
journal = {Journal international de bioethique et d'ethique des sciences},
volume = {33},
number = {1},
pages = {85-101},
doi = {10.3917/jibes.331.0085},
pmid = {35724001},
issn = {2608-1008},
abstract = {There are many reasons why we might think that the human species might be in danger. We talk about global warming which produces major unusual natural disasters; increasingly destructive weapons; serious terrorist attacks with chemical weapons, etc. But we cannot ignore one of the threats hanging over the human species, which is transhumanism or posthumanism. It is from the point of view of this last subject, on which much has already been written, that we will try to focus our analysis, paying particular attention to the question relating to gene editing (CRISPR/Cas 9).},
}

@article {pmid35722725,
year = {2022},
author = {Zhou, J and Liu, Y and Guo, X and Birchler, JA and Han, F and Su, H},
title = {Centromeres: from chromosome biology to biotechnology applications and synthetic genomes in plants.},
journal = {Plant biotechnology journal},
volume = {},
number = {},
pages = {},
doi = {10.1111/pbi.13875},
pmid = {35722725},
issn = {1467-7652},
abstract = {Centromeres are the genomic regions that organize and regulate chromosome behaviors during cell cycle, and their variations are associated with genome instability, karyotype evolution, and speciation in eukaryotes. The highly repetitive and epigenetic nature of centromeres were documented during the past half century. With the aid of rapid expansion in genomic biotechnology tools, the complete sequence and structural organization of several plant and human centromeres were revealed recently. Here, we systematically summarize the current knowledge of centromere biology with regard to the DNA compositions and the histone H3 variant (CENH3)-dependent centromere establishment and identity. We discuss the roles of centromere to ensure cell division and to maintain the three-dimensional (3D) genomic architecture in different species. We further highlight the potential applications of manipulating centromeres to generate haploids or to induce polyploids offspring in plant for breeding programs, and of targeting centromeres with CRISPR/Cas for chromosome engineering and speciation. Finally, we also assess the challenges and strategies for de novo design and synthesis of centromeres in plant artificial chromosomes. The biotechnology applications of plant centromeres will be of great potential for the genetic improvement of crops and precise synthetic breeding in the future.},
}

@article {pmid35722296,
year = {2022},
author = {Parra-Flores, J and Holý, O and Acuña, S and Lepuschitz, S and Pietzka, A and Contreras-Fernández, A and Chavarría-Sepulveda, P and Cruz-Córdova, A and Xicohtencatl-Cortes, J and Mancilla-Rojano, J and Castillo, A and Ruppitsch, W and Forsythe, S},
title = {Genomic Characterization of Cronobacter spp. and Salmonella spp. Strains Isolated From Powdered Infant Formula in Chile.},
journal = {Frontiers in microbiology},
volume = {13},
number = {},
pages = {884721},
doi = {10.3389/fmicb.2022.884721},
pmid = {35722296},
issn = {1664-302X},
abstract = {This study characterized five Cronobacter spp. and six Salmonella spp. strains that had been isolated from 155 samples of powdered infant formula (PIF) sold in Chile and manufactured in Chile and Mexico in 2018-2020. Two strains of Cronobacter sakazakii sequence type (ST) ST1 and ST31 (serotypes O:1 and O:2) and one strain of Cronobacter malonaticus ST60 (O:1) were identified. All Salmonella strains were identified as Salmonella Typhimurium ST19 (serotype O:4) by average nucleotide identity, ribosomal multilocus sequence typing (rMLST), and core genome MLST (cgMLST). The C. sakazakii and C. malonaticus isolates were resistant to cephalothin, whereas the Salmonella isolates were resistant to oxacillin and ampicillin. Nineteen antibiotic resistance genes were detected in the C. sakazakii and C. malonaticus isolates; the most prevalent were mcr-9.1, blaCSA , and blaCMA . In Salmonella, 30 genes encoding for aminoglycoside and cephalosporin resistance were identified, including aac(6')-Iaa, β-lactamases ampH, ampC1, and marA. In the Cronobacter isolates, 32 virulence-associated genes were detected by WGS and clustered as flagellar proteins, outer membrane proteins, chemotaxis, hemolysins, invasion, plasminogen activator, colonization, transcriptional regulator, survival in macrophages, use of sialic acid, and toxin-antitoxin genes. In the Salmonella strains, 120 virulence associated genes were detected, adherence, magnesium uptake, resistance to antimicrobial peptides, secretion system, stress protein, toxin, resistance to complement killing, and eight pathogenicity islands. The C. sakazakii and C. malonaticus strains harbored I-E and I-F CRISPR-Cas systems and carried Col(pHHAD28) and IncFIB(pCTU1) plasmids, respectively. The Salmonella strains harbored type I-E CRISPR-Cas systems and carried IncFII(S) plasmids. The presence of C. sakazakii and Salmonella in PIF is a health risk for infants aged less than 6 months. For this reason, sanitary practices should be reinforced for its production and retail surveillance.},
}

@article {pmid35722276,
year = {2022},
author = {Panahi, B and Majidi, M and Hejazi, MA},
title = {Genome Mining Approach Reveals the Occurrence and Diversity Pattern of Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-Associated Systems in Lactobacillus brevis Strains.},
journal = {Frontiers in microbiology},
volume = {13},
number = {},
pages = {911706},
doi = {10.3389/fmicb.2022.911706},
pmid = {35722276},
issn = {1664-302X},
abstract = {Clustered regularly interspaced short palindromic repeats (CRISPR) together with their CRISPR-associated (Cas) genes are widely distributed in prokaryotes that provide an adaptive defense mechanism against foreign invasive DNA. There is relatively little knowledge about the CRISPR-Cas diversity and evolution in Lactobacillus brevis strains. Therefore, in this study, a genome-mining approach was employed to investigate the diversity and occurrence of the CRISPR-Cas system in 83 L. brevis strains. Moreover, trans-activating CRISPR RNA (tracrRNA) and protospacer adjacent motif (PAM) as pivotal elements for the successful targeting and inference of phages by the subtype II CRISPR-Cas systems were surveyed. Finally, evolutionary paths of L. brevis strains under selective pressure from foreign invasive DNA such as plasmids and phages of studied strains were surveyed using acquisition and deletion events analysis of spacers. A total of 127 confirmed CRISPRs were identified, which were distributed in 69 strains. Among strains with confirmed CRISPRs, 35 strains only contained one CRISPR locus, 23 strains contained two CRISPR loci, and 12 strains contained three to six CRISPR loci. L. brevis strains frequently harbor more than one CRISPR system. Analysis of confirmed CRISPR arrays showed that 31 out of 127 confirmed CRISPRs included Cas genes which were categorized as one of the II-A, II-C, and I-E subtypes. Analysis of subtype II-A spacers reflected divergent evolution for 18 strains into 16 unique groups. Additional analysis of spacer sequences also confirmed the implication of characterizing CRISPR-Cas systems in targeting of phages and plasmids. The current study highlighted the potential of utilizing CRISPR spacer polymorphism in genotyping lactobacillus strains. Moreover, it provides deep insights into the occurrence, diversity, and functional impacts of the CRISPR-Cas system in L. brevis strains.},
}

@article {pmid35721864,
year = {2022},
author = {Zhang, Y and Ge, H and Marchisio, MA},
title = {A Mutated Nme1Cas9 Is a Functional Alternative RNase to Both LwaCas13a and RfxCas13d in the Yeast S. cerevisiae.},
journal = {Frontiers in bioengineering and biotechnology},
volume = {10},
number = {},
pages = {922949},
doi = {10.3389/fbioe.2022.922949},
pmid = {35721864},
issn = {2296-4185},
abstract = {CRISPR-Cas systems provide powerful biological tools for genetic manipulation and gene expression regulation. Class 2 systems, comprising type II, type V, and type VI, have the significant advantage to require a single effector Cas protein (Cas9, Cas12, and Cas13 respectively) to cleave nucleic acids upon binding the crRNA. Both Cas9 and Cas12 recognize DNA and induce a double-strand break in it. In contrast, Cas13 bind and cleave RNA exclusively. However, some Cas9 homologs have shown RNase activity as well. Here, we harnessed Nme1Cas9, LwaCas13a, and RfxCas13d to carry out gene downregulation in Saccharomyces cerevisiae by triggering mRNA degradation. To avoid potential DNA damage, we mutated Nme1Cas9 into d16ANme1Cas9 that lost the nuclease activity of the RuvC domain but retained the active HNH domain, able to act on the target DNA strand and, therefore, on the corresponding transcript. Our results showed that d16ANme1Cas9 is a functional RNase in vivo, although with moderate activity since it provoked a fluorescence reduction from 21% to 32%. Interestingly, d16ANme1Cas9 works in a PAM-independent way nor demands helper PAMmer molecules. LwaCas13a and RfxCas13d appeared substantially unfunctional in S. cerevisiae, though they were shown to perform well in mammalian cells. To the best of our knowledge, this is the first report about the working in vivo of a variant of Nme1Cas9 as an RNase and the issues connected with the usage of Cas13 proteins in S. cerevisiae.},
}

@article {pmid35719725,
year = {2022},
author = {Chilian, M and Vargas Parra, K and Sandoval, A and Ramirez, J and Yoon, WH},
title = {CRISPR/Cas9-mediated tissue-specific knockout and cDNA rescue using sgRNAs that target exon-intron junctions in Drosophila melanogaster.},
journal = {STAR protocols},
volume = {3},
number = {3},
pages = {101465},
doi = {10.1016/j.xpro.2022.101465},
pmid = {35719725},
issn = {2666-1667},
mesh = {Animals ; *CRISPR-Cas Systems/genetics ; DNA, Complementary/genetics ; Drosophila/genetics ; *Drosophila melanogaster/genetics ; Exons/genetics ; Introns ; },
abstract = {In this protocol, we take CRISPR/Cas9 and Gal4/UAS approaches to achieve tissue-specific knockout in parallel with rescue of the knockout by cDNA expression in Drosophila. We demonstrate that guide RNAs targeting the exon-intron junction of target genes cleave the genomic locus of the genes, but not UAS-cDNA transgenes, in a tissue where Gal4 drives Cas9 expression. The efficiency of this approach enables the determination of pathogenicity of disease-associated variants in human genes in a tissue-specific manner in Drosophila. For complete details on the use and execution of this protocol, please refer to Yap et al. (2021).},
}

Animals
*CRISPR-Cas Systems/genetics
DNA, Complementary/genetics
Drosophila/genetics
*Drosophila melanogaster/genetics
Exons/genetics
Introns

@article {pmid35719360,
year = {2022},
author = {Qiu, X and Xu, S and Liu, X and Ren, H and Han, L and Li, Z},
title = {CRISPR/Cas12a-Based Diagnostic Platform Accurately Detects Nocardia farcinica Targeting a Novel Species-Specific Gene.},
journal = {Frontiers in cellular and infection microbiology},
volume = {12},
number = {},
pages = {884411},
doi = {10.3389/fcimb.2022.884411},
pmid = {35719360},
issn = {2235-2988},
mesh = {*COVID-19 ; CRISPR-Cas Systems ; Humans ; Nocardia ; *Nocardia Infections ; *Nucleic Acids ; Pandemics ; },
abstract = {Under the COVID-19 pandemic background, nucleic acid detection has become the gold standard to rapidly diagnose the infectious disease. A rapid, low cost, reliable nucleic acid detection platform will be the key to control next potential pandemic. In this study, a nucleic acid detection platform, which combined CRISPR/Cas12a-based detection with loop-mediated isothermal amplification (LAMP), was developed and termed CRISPR-CLA. In the CRISPR-CLA system, LAMP preamplification was employed, and CRISPR/Cas12a-based detection was used to monitor the preamplicons. The forward inner primer (FIP) was engineered with a protospacer adjacent motif (PAM) site TTTA of Cas12a effector at the linker region; thus, the CRISPR-CLA platform can detect any sequence as long as the primer design meets the requirement of LAMP. To demonstrate the validity of the CRISPR-CLA system, it was applied for the molecular diagnosis of nocardiosis caused by Nocardia farcinica (N. farcinica). A highly conserved and species-specific gene pbr1 of N. farcinica, which was first reported in this study, was used as the target of detection. A set of LAMP primers targeting a fragment of pbr1 of the N. farcinica reference strain IFM 10152 was designed according to the principle of CRISPR-CLA. Three CRISPR RNAs (crRNAs) with different lengths were designed, and the most efficient crRNA was screened out. Additionally, three single-strand DNA (ssDNA) probes were tested to further optimize the detection system. As a result, the N. farcinica CRISPR-CLA assay was established, and the whole detection process, including DNA extraction (20 min), LAMP preamplification (70°C, 40 min), and CRISPR/Cas12a-mediated detection (37°C, 8 min), can be completed within 70 min. A fluorescence reader (for fluorescence CRISPR-CLA) or a lateral flow biosensor (for lateral-flow CRISPR-CLA) can be the media of the result readout. Up to 132 strains were used to examine the specificity of N. farcinica CRISPR-CLA assay, and no cross-reaction was observed with non-N. farcinica templates. The limit of detection (LoD) of the N. farcinica CRISPR-CLA assay was 100 fg double-strand DNA per reaction. N. farcinica was detected accurately in 41 sputum specimens using the N. farcinica CRISPR-CLA assay, which showed higher specificity than a real-time qPCR method. Hence, the N. farcinica CRISPR-CLA assay is a rapid, economic and accurate method to diagnose N. farcinica infection.},
}

*COVID-19
CRISPR-Cas Systems
Humans
Nocardia
*Nocardia Infections
*Nucleic Acids
Pandemics

@article {pmid35717416,
year = {2022},
author = {Velimirovic, M and Zanetti, LC and Shen, MW and Fife, JD and Lin, L and Cha, M and Akinci, E and Barnum, D and Yu, T and Sherwood, RI},
title = {Peptide fusion improves prime editing efficiency.},
journal = {Nature communications},
volume = {13},
number = {1},
pages = {3512},
pmid = {35717416},
issn = {2041-1723},
support = {1R01HG008754//U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (NHGRI)/ ; 1R21HG010391//U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (NHGRI)/ ; },
mesh = {*CRISPR-Cas Systems ; Cell Line ; *Gene Editing ; Gene Fusion ; Peptides/genetics ; },
abstract = {Prime editing enables search-and-replace genome editing but is limited by low editing efficiency. We present a high-throughput approach, the Peptide Self-Editing sequencing assay (PepSEq), to measure how fusion of 12,000 85-amino acid peptides influences prime editing efficiency. We show that peptide fusion can enhance prime editing, prime-enhancing peptides combine productively, and a top dual peptide-prime editor increases prime editing significantly in multiple cell lines across dozens of target sites. Top prime-enhancing peptides function by increasing translation efficiency and serve as broadly useful tools to improve prime editing efficiency.},
}

*CRISPR-Cas Systems
Cell Line
*Gene Editing
Gene Fusion
Peptides/genetics

@article {pmid35716656,
year = {2022},
author = {Ali, S and Khan, N and Tang, Y},
title = {Epigenetic marks for mitigating abiotic stresses in plants.},
journal = {Journal of plant physiology},
volume = {275},
number = {},
pages = {153740},
doi = {10.1016/j.jplph.2022.153740},
pmid = {35716656},
issn = {1618-1328},
abstract = {Abiotic stressors are one of the major factors affecting agricultural output. Plants have evolved adaptive systems to respond appropriately to various environmental cues. These responses can be accomplished by modulating or fine-tuning genetic and epigenetic regulatory mechanisms. Understanding the response of plants' molecular features to abiotic stress is a priority in the current period of continued environmental changes. Epigenetic modifications are necessary that control gene expression by changing chromatin status and recruiting various transcription regulators. The present study summarized the current knowledge on epigenetic modifications concerning plant responses to various environmental stressors. The functional relevance of epigenetic marks in regulating stress tolerance has been revealed, and epigenetic changes impact the effector genes. This study looks at the epigenetic mechanisms that govern plant abiotic stress responses, especially DNA methylation, histone methylation/acetylation, chromatin remodeling, and various metabolites. Plant breeders will benefit from a thorough understanding of these processes to create alternative crop improvement approaches. Genome editing with clustered regularly interspaced short palindromic repeat/CRISPR-associated proteins (CRISPR/Cas) provides genetic tools to make agricultural genetic engineering more sustainable and publicly acceptable.},
}

@article {pmid35715136,
year = {2022},
author = {Taghdisi, SM and Ramezani, M and Alibolandi, M and Khademi, Z and Hajihasani, MM and Alinezhad Nameghi, M and Khakshour Abdolabadi, A and Rahimi, H and Abnous, K and Danesh, NM},
title = {A highly sensitive fluorescent aptasensor for detection of prostate specific antigen based on the integration of a DNA structure and CRISPR-Cas12a.},
journal = {Analytica chimica acta},
volume = {1219},
number = {},
pages = {340031},
doi = {10.1016/j.aca.2022.340031},
pmid = {35715136},
issn = {1873-4324},
mesh = {*Biosensing Techniques/methods ; CRISPR-Cas Systems ; DNA/genetics ; DNA, Cruciform ; Humans ; Male ; *Prostate-Specific Antigen ; },
abstract = {Herein, a facile fluorescent CRISPR-Cas12a-based sensing strategy is presented for prostate specific antigen (PSA), as a prostate cancer biomarker, with the assistance of a cruciform DNA nanostructure and PicoGreen (PG) as a fluorochrome. Highly sensitive recognition of PSA is one of the virtues of the proposed method which comes from the use of unique features of both CRISPR-Cas12a and DNA structure in the design of the aptasensor. The presence of PSA creates a cruciform DNA nanostructure in the sample which can be loaded by PG and make sharp fluorescence emission. While, when there is no PSA, the CRISPR-Cas12a digests sequences 1 and 3 as single-stranded DNAs, causing no DNA structure and a negligible fluorescence is detected after addition of PG. This aptasensor presents a sensitive recognition performance with detection limit of 4 pg/mL and a practical use for determination of PSA in serum samples. So, this analytical strategy introduces a convenient and highly sensitive approach for detection of disease biomarkers.},
}

*Biosensing Techniques/methods
CRISPR-Cas Systems
DNA/genetics
DNA, Cruciform
Humans
Male
*Prostate-Specific Antigen

@article {pmid35713718,
year = {2022},
author = {Rather, GA and Ayzenshtat, D and Teper-Bamnolker, P and Kumar, M and Forotan, Z and Eshel, D and Bocobza, S},
title = {Advances in protoplast transfection promote efficient CRISPR/Cas9-mediated genome editing in tetraploid potato.},
journal = {Planta},
volume = {256},
number = {1},
pages = {14},
pmid = {35713718},
issn = {1432-2048},
support = {20-01-0209//Office of the Chief Scientist, Ministry of Health/ ; },
mesh = {CRISPR-Cas Systems/genetics ; DNA/metabolism ; *Gene Editing/methods ; Genome, Plant ; Kanamycin/metabolism ; Plant Breeding/methods ; Protoplasts/metabolism ; *Solanum tuberosum/genetics/metabolism ; Tetraploidy ; Transcription Factors/genetics ; Transfection ; },
abstract = {MAIN CONCLUSION: An efficient method of DNA-free gene-editing in potato protoplasts was developed using linearized DNA fragments, UBIQUITIN10 promoters of several plant species, kanamycin selection, and transient overexpression of the BABYBOOM transcription factor. Plant protoplasts represent a reliable experimental system for the genetic manipulation of desired traits using gene editing. Nevertheless, the selection and regeneration of mutated protoplasts are challenging and subsequent recovery of successfully edited plants is a significant bottleneck in advanced plant breeding technologies. In an effort to alleviate the obstacles related to protoplasts' transgene expression and protoplasts' regeneration, a new method was developed. In so doing, it was shown that linearized DNA could efficiently transfect potato protoplasts and that UBIQUITIN10 promoters from various plants could direct transgene expression in an effective manner. Also, the inhibitory concentration of kanamycin was standardized for transfected protoplasts, and the NEOMYCIN PHOSPHOTRANSFERASE2 (NPT2) gene could be used as a potent selection marker for the enrichment of transfected protoplasts. Furthermore, transient expression of the BABYBOOM (BBM) transcription factor promoted the regeneration of protoplast-derived calli. Together, these methods significantly increased the selection for protoplasts that displayed high transgene expression, and thereby significantly increased the rate of gene editing events in protoplast-derived calli to 95%. The method developed in this study facilitated gene-editing in tetraploid potato plants and opened the way to sophisticated genetic manipulation in polyploid organisms.},
}

CRISPR-Cas Systems/genetics
DNA/metabolism
*Gene Editing/methods
Genome, Plant
Kanamycin/metabolism
Plant Breeding/methods
Protoplasts/metabolism
*Solanum tuberosum/genetics/metabolism
Tetraploidy
Transcription Factors/genetics
Transfection

@article {pmid35713220,
year = {2022},
author = {Yang, H and Wei, Y and Zhang, Q and Yang, Y and Bi, X and Yang, L and Xiao, N and Zang, A and Ren, L and Li, X},
title = {CRISPR/Cas9‑induced saturated mutagenesis identifies Rad51 haplotype as a marker of PARP inhibitor sensitivity in breast cancer.},
journal = {Molecular medicine reports},
volume = {26},
number = {2},
pages = {},
doi = {10.3892/mmr.2022.12774},
pmid = {35713220},
issn = {1791-3004},
mesh = {*Antineoplastic Agents/pharmacology ; *Breast Neoplasms/drug therapy/genetics ; CRISPR-Cas Systems/genetics ; Cell Line, Tumor ; Drug Resistance, Neoplasm/genetics ; Female ; Haplotypes ; Humans ; Mutagenesis ; Phthalazines/pharmacology/therapeutic use ; Poly(ADP-ribose) Polymerase Inhibitors/pharmacology/therapeutic use ; Rad51 Recombinase/genetics/metabolism ; },
abstract = {Breast cancer treatment with poly(ADP‑ribose)polymerase (PARP) inhibitors is currently limited to cells defective in the homologous recombination repair (HRR) pathway. The chemical inhibition of many HRR deficiency genes may sensitize cancer cells to PARP inhibitors. In the present study, Rad51, a central player in the HRR pathway, was selected to explore additional low variation and highly representative markers for PARP inhibitor activity. A CRISPR/Cas9‑based saturated mutation approach for the Rad51 WALKER domain was used to evaluate the sensitivity of the PARP inhibitor olaparib. Five amino acid mutation sites were identified in olaparib‑resistant cells. Two Rad51 haplotypes were assembled from the mutations, and may represent useful pharmacogenomic markers of PARP inhibitor sensitivity.},
}

*Antineoplastic Agents/pharmacology
*Breast Neoplasms/drug therapy/genetics
CRISPR-Cas Systems/genetics
Cell Line, Tumor
Drug Resistance, Neoplasm/genetics
Female
Haplotypes
Humans
Mutagenesis
Phthalazines/pharmacology/therapeutic use
Poly(ADP-ribose) Polymerase Inhibitors/pharmacology/therapeutic use
Rad51 Recombinase/genetics/metabolism

@article {pmid35712599,
year = {2022},
author = {Mattiello, L and Rütgers, M and Sua-Rojas, MF and Tavares, R and Soares, JS and Begcy, K and Menossi, M},
title = {Molecular and Computational Strategies to Increase the Efficiency of CRISPR-Based Techniques.},
journal = {Frontiers in plant science},
volume = {13},
number = {},
pages = {868027},
doi = {10.3389/fpls.2022.868027},
pmid = {35712599},
issn = {1664-462X},
abstract = {The prokaryote-derived Clustered Regularly Interspaced Palindromic Repeats (CRISPR)/Cas mediated gene editing tools have revolutionized our ability to precisely manipulate specific genome sequences in plants and animals. The simplicity, precision, affordability, and robustness of this technology have allowed a myriad of genomes from a diverse group of plant species to be successfully edited. Even though CRISPR/Cas, base editing, and prime editing technologies have been rapidly adopted and implemented in plants, their editing efficiency rate and specificity varies greatly. In this review, we provide a critical overview of the recent advances in CRISPR/Cas9-derived technologies and their implications on enhancing editing efficiency. We highlight the major efforts of engineering Cas9, Cas12a, Cas12b, and Cas12f proteins aiming to improve their efficiencies. We also provide a perspective on the global future of agriculturally based products using DNA-free CRISPR/Cas techniques. The improvement of CRISPR-based technologies efficiency will enable the implementation of genome editing tools in a variety of crop plants, as well as accelerate progress in basic research and molecular breeding.},
}

@article {pmid35712010,
year = {2022},
author = {Novarina, D and Koutsoumpa, A and Milias-Argeitis, A},
title = {A user-friendly and streamlined protocol for CRISPR/Cas9 genome editing in budding yeast.},
journal = {STAR protocols},
volume = {3},
number = {2},
pages = {101358},
doi = {10.1016/j.xpro.2022.101358},
pmid = {35712010},
issn = {2666-1667},
mesh = {CRISPR-Cas Systems/genetics ; *Gene Editing/methods ; Plasmids/genetics ; Saccharomyces cerevisiae/genetics ; *Saccharomycetales/genetics ; },
abstract = {CRISPR/Cas9 technology allows accurate, marker-less genome editing. We report a detailed, robust, and streamlined protocol for CRISPR/Cas9 genome editing in Saccharomyces cerevisiae, based on the widely used MoClo-Yeast Toolkit (https://www.addgene.org/kits/moclo-ytk/). This step-by-step protocol guides the reader from sgRNA design to verification of the desired genome editing event and provides preassembled plasmids for cloning the sgRNA(s), making this technology easily accessible to any yeast research group. For complete details on the use and execution of this protocol, please refer to Novarina et al. (2021).},
}

CRISPR-Cas Systems/genetics
*Gene Editing/methods
Plasmids/genetics
Saccharomyces cerevisiae/genetics
*Saccharomycetales/genetics

@article {pmid35711363,
year = {2022},
author = {Wang, Q and Park, KH and Geng, B and Chen, P and Yang, C and Jiang, Q and Yi, F and Tan, T and Zhou, X and Bian, Z and Ma, J and Zhu, H},
title = {MG53 Inhibits Necroptosis Through Ubiquitination-Dependent RIPK1 Degradation for Cardiac Protection Following Ischemia/Reperfusion Injury.},
journal = {Frontiers in cardiovascular medicine},
volume = {9},
number = {},
pages = {868632},
doi = {10.3389/fcvm.2022.868632},
pmid = {35711363},
issn = {2297-055X},
abstract = {Rationale: While reactive oxygen species (ROS) has been recognized as one of the main causes of cardiac injury following myocardial infarction, the clinical application of antioxidants has shown limited effects on protecting hearts against ischemia-reperfusion (I/R) injury. Thus, the precise role of ROS following cardiac injury remains to be fully elucidated.

Objective: We investigated the role of mitsugumin 53 (MG53) in regulating necroptosis following I/R injury to the hearts and the involvement of ROS in MG53-mediated cardioprotection.

Methods and Results: Antioxidants were used to test the role of ROS in MG53-mediated cardioprotection in the mouse model of I/R injury and induced human pluripotent stem cells (hiPSCs)-derived cardiomyocytes subjected to hypoxia or re-oxygenation (H/R) injury. Western blotting and co-immunoprecipitation were used to identify potential cell death pathways that MG53 was involved in. CRISPR/Cas 9-mediated genome editing and mutagenesis assays were performed to further identify specific interaction amino acids between MG53 and its ubiquitin E3 ligase substrate. We found that MG53 could protect myocardial injury via inhibiting the necroptosis pathway. Upon injury, the generation of ROS in the infarct zone of the hearts promoted interaction between MG53 and receptor-interacting protein kinase 1 (RIPK1). As an E3 ubiquitin ligase, MG53 added multiple ubiquitin chains to RIPK1 at the sites of K316, K604, and K627 for proteasome-mediated RIPK1 degradation and inhibited necroptosis. The application of N-acetyl cysteine (NAC) disrupted the interaction between MG53 and RIPK1 and abolished MG53-mediated cardioprotective effects.

Conclusions: Taken together, this study provided a molecular mechanism of a potential beneficial role of ROS following acute myocardial infarction. Thus, fine-tuning ROS levels might be critical for cardioprotection.},
}

@article {pmid35711292,
year = {2022},
author = {Bhattacharjee, R and Nandi, A and Mitra, P and Saha, K and Patel, P and Jha, E and Panda, PK and Singh, SK and Dutt, A and Mishra, YK and Verma, SK and Suar, M},
title = {Theragnostic application of nanoparticle and CRISPR against food-borne multi-drug resistant pathogens.},
journal = {Materials today. Bio},
volume = {15},
number = {},
pages = {100291},
doi = {10.1016/j.mtbio.2022.100291},
pmid = {35711292},
issn = {2590-0064},
abstract = {Foodborne infection is one of the leading sources of infections spreading across the world. Foodborne pathogens are recognized as multidrug-resistant (MDR) pathogens posing a significant problem in the food industry and healthy consumers resulting in enhanced economic burden, and nosocomial infections. The continued search for enhanced microbial detection tools has piqued the interest of the CRISPR-Cas system and Nanoparticles. CRISPR-Cas system is present in the bacterial genome of some prokaryotes and is repurposed as a theragnostic tool against MDR pathogens. Nanoparticles and composites have also emerged as an efficient tool in theragnostic applications against MDR pathogens. The diagnostic limitations of the CRISPR-Cas system are believed to be overcome by a synergistic combination of the nanoparticles system and CRISPR-Cas using nanoparticles as vehicles. In this review, we have discussed the diagnostic application of CRISPR-Cas technologies along with their potential usage in applications like phage resistance, phage vaccination, strain typing, genome editing, and antimicrobial. we have also elucidated the antimicrobial and detection role of nanoparticles against foodborne MDR pathogens. Moreover, the novel combinatorial approach of CRISPR-Cas and nanoparticles for their synergistic effects in pathogen clearance and drug delivery vehicles has also been discussed.},
}

@article {pmid35710827,
year = {2022},
author = {Ryu, J and Statz, JP and Chan, W and Burch, FC and Brigande, JV and Kempton, B and Porsov, EV and Renner, L and McGill, T and Burwitz, BJ and Hanna, CB and Neuringer, M and Hennebold, JD},
title = {CRISPR/Cas9 editing of the MYO7A gene in rhesus macaque embryos to generate a primate model of Usher syndrome type 1B.},
journal = {Scientific reports},
volume = {12},
number = {1},
pages = {10036},
pmid = {35710827},
issn = {2045-2322},
support = {P51 OD011092/GF/NIH HHS/United States ; },
mesh = {Animals ; CRISPR-Cas Systems ; Endonucleases/genetics ; Gene Editing ; Humans ; Macaca mulatta/genetics/metabolism ; RNA, Guide/metabolism ; RNA, Messenger ; *Usher Syndromes/genetics ; },
abstract = {Mutations in the MYO7A gene lead to Usher syndrome type 1B (USH1B), a disease characterized by congenital deafness, vision loss, and balance impairment. To create a nonhuman primate (NHP) USH1B model, CRISPR/Cas9 was used to disrupt MYO7A in rhesus macaque zygotes. The targeting efficiency of Cas9 mRNA and hybridized crRNA-tracrRNA (hyb-gRNA) was compared to Cas9 nuclease (Nuc) protein and synthetic single guide (sg)RNAs. Nuc/sgRNA injection led to higher editing efficiencies relative to mRNA/hyb-gRNAs. Mutations were assessed by preimplantation genetic testing (PGT) and those with the desired mutations were transferred into surrogates. A pregnancy was established from an embryo where 92.1% of the PGT sequencing reads possessed a single G insertion that leads to a premature stop codon. Analysis of single peripheral blood leukocytes from the infant revealed that half the cells possessed the homozygous single base insertion and the remaining cells had the wild-type MYO7A sequence. The infant showed sensitive auditory thresholds beginning at 3 months. Although further optimization is needed, our studies demonstrate that it is feasible to use CRISPR technologies for creating NHP models of human diseases.},
}

Animals
CRISPR-Cas Systems
Endonucleases/genetics
Gene Editing
Humans
Macaca mulatta/genetics/metabolism
RNA, Guide/metabolism
RNA, Messenger
*Usher Syndromes/genetics

@article {pmid35705772,
year = {2022},
author = {Wang, Y and Huang, C and Zhao, W},
title = {Recent advances of the biological and biomedical applications of CRISPR/Cas systems.},
journal = {Molecular biology reports},
volume = {},
number = {},
pages = {},
pmid = {35705772},
issn = {1573-4978},
support = {2020M683751//Postdoctoral Research Foundation of China/ ; 2021JQ-559//Natural Science Foundation of Shaanxi Province/ ; },
abstract = {The clustered, regularly interspaced, short palindromic repeats (CRISPR)-associated endonuclease (Cas) system, referred to as CRISPR/Cas system, has attracted significant interest in scientific community due to its great potential in translating into versatile therapeutic tools in biomedical field. For instance, a myriad of studies has demonstrated that the CRISPR/Cas system is capable of detecting various types of viruses, killing antibiotic-resistant bacteria, treating inherited genetic diseases, and providing new strategies for cancer therapy. Furthermore, CRISPR/Cas systems are also exploited as research tools such as genome engineering tool that allows researchers to interrogate the biological roles of unexplored genes or uncover novel functions of known genes. Additionally, the CRISPR/Cas system has been employed to edit the genome of a wide range of eukaryotic, prokaryotic organisms and experimental models, including but not limited to mammalian cells, mice, zebrafish, plants, yeast, and Escherichia coli. The present review mainly focuses on summarizing recent discoveries regarding the type II CRISPR/Cas9 and type VI CRISPR/Cas13a systems to give researchers a glimpse of their potential applications in the biological and biomedical field.},
}

@article {pmid35705709,
year = {2022},
author = {},
title = {Caribou's first CRISPR CAR-T impresses.},
journal = {Nature biotechnology},
volume = {40},
number = {6},
pages = {807},
doi = {10.1038/s41587-022-01371-6},
pmid = {35705709},
issn = {1546-1696},
mesh = {Animals ; CRISPR-Cas Systems/genetics ; Clustered Regularly Interspaced Short Palindromic Repeats/genetics ; Gene Editing ; Immunotherapy, Adoptive ; Receptors, Antigen, T-Cell/genetics ; *Receptors, Chimeric Antigen/metabolism ; *Reindeer/metabolism ; },
}

Animals
CRISPR-Cas Systems/genetics
Clustered Regularly Interspaced Short Palindromic Repeats/genetics
Gene Editing
Immunotherapy, Adoptive
Receptors, Antigen, T-Cell/genetics
*Receptors, Chimeric Antigen/metabolism
*Reindeer/metabolism

@article {pmid35705705,
year = {2022},
author = {},
title = {CRISPR technology.},
journal = {Nature biotechnology},
volume = {40},
number = {6},
pages = {832},
doi = {10.1038/s41587-022-01359-2},
pmid = {35705705},
issn = {1546-1696},
mesh = {CRISPR-Cas Systems/genetics ; *Clustered Regularly Interspaced Short Palindromic Repeats/genetics ; *Gene Editing ; Technology ; },
}

CRISPR-Cas Systems/genetics
*Clustered Regularly Interspaced Short Palindromic Repeats/genetics
*Gene Editing
Technology

@article {pmid35708998,
year = {2022},
author = {Gemperle, J and Harrison, TS and Flett, C and Adamson, AD and Caswell, PT},
title = {On demand expression control of endogenous genes with DExCon, DExogron and LUXon reveals differential dynamics of Rab11 family members.},
journal = {eLife},
volume = {11},
number = {},
pages = {},
doi = {10.7554/eLife.76651},
pmid = {35708998},
issn = {2050-084X},
support = {DCRPGF\100002/CRUK_/Cancer Research UK/United Kingdom ; 836212//Horizon 2020 Framework Programme/ ; C147/A25254/CRUK_/Cancer Research UK/United Kingdom ; MR/R009376/1/MRC_/Medical Research Council/United Kingdom ; 203128/A/16/Z/WT_/Wellcome Trust/United Kingdom ; },
mesh = {CRISPR-Cas Systems ; *Doxycycline ; Indoleacetic Acids ; Methacrylates ; *rab GTP-Binding Proteins/genetics/metabolism ; },
abstract = {CRISPR technology has made generation of gene knock-outs widely achievable in cells. However, once inactivated, their re-activation remains difficult, especially in diploid cells. Here, we present DExCon (Doxycycline-mediated endogenous gene Expression Control), DExogron (DExCon combined with auxin-mediated targeted protein degradation), and LUXon (light responsive DExCon) approaches which combine one-step CRISPR-Cas9-mediated targeted knockin of fluorescent proteins with an advanced Tet-inducible TRE3GS promoter. These approaches combine blockade of active gene expression with the ability to re-activate expression on demand, including activation of silenced genes. Systematic control can be exerted using doxycycline or spatiotemporally by light, and we demonstrate functional knock-out/rescue in the closely related Rab11 family of vesicle trafficking regulators. Fluorescent protein knock-in results in bright signals compatible with low-light live microscopy from monoallelic modification, the potential to simultaneously image different alleles of the same gene, and bypasses the need to work with clones. Protein levels are easily tunable to correspond with endogenous expression through cell sorting (DExCon), timing of light illumination (LUXon), or by exposing cells to different levels of auxin (DExogron). Furthermore, our approach allowed us to quantify previously unforeseen differences in vesicle dynamics, transferrin receptor recycling, expression kinetics, and protein stability among highly similar endogenous Rab11 family members and their colocalization in triple knock-in ovarian cancer cell lines.},
}

CRISPR-Cas Systems
*Doxycycline
Indoleacetic Acids
Methacrylates
*rab GTP-Binding Proteins/genetics/metabolism

@article {pmid35707386,
year = {2022},
author = {Zhang, YY and Li, SQ and Song, Y and Wang, P and Song, XG and Zhu, WF and Wang, DM},
title = {Silencing the ADAM9 Gene through CRISPR/Cas9 Protects Mice from Alcohol-Induced Acute Liver Injury.},
journal = {BioMed research international},
volume = {2022},
number = {},
pages = {5110161},
doi = {10.1155/2022/5110161},
pmid = {35707386},
issn = {2314-6141},
mesh = {Animals ; *CRISPR-Cas Systems ; Cells, Cultured ; Disease Models, Animal ; Gene Editing ; Liver ; Mice ; *RNA, Guide/genetics ; },
abstract = {Alcoholic liver injury is a major global public health concern at present. The ADAM9 gene plays a crucial role in the occurrence and development of various liver diseases, but its role in acute alcoholic liver injury remains ambiguous. In this study, a chimeric single-guide RNA targeting the genomic regions of mouse ADAM9 was designed using the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) technology. Next, the role of ADAM9 in acute alcoholic liver injury in vitro in cultured mouse cells and in vivo in a hydrodynamic injection-based alcoholic liver injury mouse model was documented. The findings of this study suggest that ADAM9 induces by regulating cell proliferation, apoptosis, and stress metabolism in mice. Thus, inhibiting the expression of ADAM9 gene using CRISPR/Cas9 can attenuate alcohol-induced acute liver injury in mice.},
}

Animals
*CRISPR-Cas Systems
Cells, Cultured
Disease Models, Animal
Gene Editing
Liver
Mice
*RNA, Guide/genetics

@article {pmid35703314,
year = {2022},
author = {Inwood, SL and Tian, L and Parratt, K and Maragh, S and Wang, L},
title = {Evaluation protocol for CRISPR/Cas9-mediated CD19 knockout GM24385 cells by flow cytometry and Sanger sequencing.},
journal = {BioTechniques},
volume = {72},
number = {6},
pages = {279-286},
doi = {10.2144/btn-2022-0015},
pmid = {35703314},
issn = {1940-9818},
support = {//Material Measurement Laboratory/ ; },
mesh = {*CRISPR-Cas Systems/genetics ; Cell Line ; Flow Cytometry ; *Gene Editing/methods ; },
abstract = {Although several genome editing options are available, CRISPR/Cas9 is one of the most commonly used systems for protein and advanced therapies. There are some long-term data regarding genomic and phenotypic stability, however, information is sparse. Flow cytometry can offer a method to characterize these edited cells for longitudinal studies. The objective of this work is to describe a protocol for using flow cytometry to measure the edits from CRISPR/Cas9 on a well-characterized B-lymphoblast cell line, GM24385, with the goal of supporting safe and effective CRISPR/Cas9-engineered therapies.},
}

*CRISPR-Cas Systems/genetics
Cell Line
Flow Cytometry
*Gene Editing/methods

@article {pmid35701478,
year = {2022},
author = {Rosello, M and Serafini, M and Mignani, L and Finazzi, D and Giovannangeli, C and Mione, MC and Concordet, JP and Del Bene, F},
title = {Disease modeling by efficient genome editing using a near PAM-less base editor in vivo.},
journal = {Nature communications},
volume = {13},
number = {1},
pages = {3435},
pmid = {35701478},
issn = {2041-1723},
mesh = {Animals ; *CRISPR-Associated Protein 9/metabolism ; CRISPR-Cas Systems/genetics ; *Gene Editing/methods ; Genome/genetics ; Zebrafish/genetics/metabolism ; },
abstract = {Base Editors are emerging as an innovative technology to introduce point mutations in complex genomes. So far, the requirement of an NGG Protospacer Adjacent Motif (PAM) at a suitable position often limits the base editing possibility to model human pathological mutations in animals. Here we show that, using the CBE4max-SpRY variant recognizing nearly all PAM sequences, we could introduce point mutations for the first time in an animal model with high efficiency, thus drastically increasing the base editing possibilities. With this near PAM-less base editor we could simultaneously mutate several genes and we developed a co-selection method to identify the most edited embryos based on a simple visual screening. Finally, we apply our method to create a zebrafish model for melanoma predisposition based on the simultaneous base editing of multiple genes. Altogether, our results considerably expand the Base Editor application to introduce human disease-causing mutations in zebrafish.},
}

Animals
*CRISPR-Associated Protein 9/metabolism
CRISPR-Cas Systems/genetics
*Gene Editing/methods
Genome/genetics
Zebrafish/genetics/metabolism

@article {pmid35701417,
year = {2022},
author = {Teufel, M and Klein, CA and Mager, M and Sobetzko, P},
title = {A multifunctional system for genome editing and large-scale interspecies gene transfer.},
journal = {Nature communications},
volume = {13},
number = {1},
pages = {3430},
pmid = {35701417},
issn = {2041-1723},
support = {SO 1447/5-1//Deutsche Forschungsgemeinschaft (German Research Foundation)/ ; },
mesh = {*CRISPR-Cas Systems/genetics ; DNA/genetics ; Escherichia coli/genetics ; *Gene Editing ; Genetic Therapy ; Genome, Bacterial/genetics ; },
abstract = {CRISPR SWAPnDROP extends the limits of genome editing to large-scale in-vivo DNA transfer between bacterial species. Its modular platform approach facilitates species specific adaptation to confer genome editing in various species. In this study, we show the implementation of the CRISPR SWAPnDROP concept for the model organism Escherichia coli, the fast growing Vibrio natriegens and the plant pathogen Dickeya dadantii. We demonstrate the excision, transfer and integration of large chromosomal regions between E. coli, V. natriegens and D. dadantii without size-limiting intermediate DNA extraction. CRISPR SWAPnDROP also provides common genome editing approaches comprising scarless, marker-free, iterative and parallel insertions and deletions. The modular character facilitates DNA library applications, and recycling of standardized parts. Its multi-color scarless co-selection system significantly improves editing efficiency and provides visual quality controls throughout the assembly and editing process.},
}

*CRISPR-Cas Systems/genetics
DNA/genetics
Escherichia coli/genetics
*Gene Editing
Genetic Therapy
Genome, Bacterial/genetics

@article {pmid35701408,
year = {2022},
author = {Kosicki, M and Allen, F and Steward, F and Tomberg, K and Pan, Y and Bradley, A},
title = {Cas9-induced large deletions and small indels are controlled in a convergent fashion.},
journal = {Nature communications},
volume = {13},
number = {1},
pages = {3422},
pmid = {35701408},
issn = {2041-1723},
support = {098051/WT_/Wellcome Trust/United Kingdom ; },
mesh = {Animals ; *CRISPR-Cas Systems ; *DNA Breaks, Double-Stranded ; DNA End-Joining Repair/genetics ; DNA Repair/genetics ; INDEL Mutation ; Mice ; },
abstract = {Repair of Cas9-induced double-stranded breaks results primarily in formation of small insertions and deletions (indels), but can also cause potentially harmful large deletions. While mechanisms leading to the creation of small indels are relatively well understood, very little is known about the origins of large deletions. Using a library of clonal NGS-validated mouse embryonic stem cells deficient for 32 DNA repair genes, we have shown that large deletion frequency increases in cells impaired for non-homologous end joining and decreases in cells deficient for the central resection gene Nbn and the microhomology-mediated end joining gene Polq. Across deficient clones, increase in large deletion frequency was closely correlated with the increase in the extent of microhomology and the size of small indels, implying a continuity of repair processes across different genomic scales. Furthermore, by targeting diverse genomic sites, we identified examples of repair processes that were highly locus-specific, discovering a role for exonuclease Trex1. Finally, we present evidence that indel sizes increase with the overall efficiency of Cas9 mutagenesis. These findings may have impact on both basic research and clinical use of CRISPR-Cas9, in particular in conjunction with repair pathway modulation.},
}

Animals
*CRISPR-Cas Systems
*DNA Breaks, Double-Stranded
DNA End-Joining Repair/genetics
DNA Repair/genetics
INDEL Mutation
Mice

@article {pmid35696571,
year = {2022},
author = {Simonetti, B and Daly, JL and Simón-Gracia, L and Klein, K and Weeratunga, S and Antón-Plágaro, C and Tobi, A and Hodgson, L and Lewis, PA and Heesom, KJ and Shoemark, DK and Davidson, AD and Collins, BM and Teesalu, T and Yamauchi, Y and Cullen, PJ},
title = {ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.},
journal = {Proceedings of the National Academy of Sciences of the United States of America},
volume = {119},
number = {25},
pages = {e2201980119},
doi = {10.1073/pnas.2201980119},
pmid = {35696571},
issn = {1091-6490},
support = {104568/Z/14/Z//Wellcome Trust (WT)/ ; 20260/Z/20/Z//Wellcome Trust (WT)/ ; MR/L007363/1//UKRI | Medical Research Council (MRC)/ ; MR/P018807/1//UKRI | Medical Research Council (MRC)/ ; RSRP/R1/211004//Royal Society (The Royal Society)/ ; 203959/Z/16/Z//Wellcome Trust (WT)/ ; BB/L01386X/1//UKRI | Biotechnology and Biological Sciences Research Council (BBSRC)/ ; APP1136021//Department of Health | National Health and Medical Research Council (NHMRC)/ ; APP1156493//Department of Health | National Health and Medical Research Council (NHMRC)/ ; No 856581 - CHUbVi).//EC | H2020 | H2020 Priority Excellent Science | H2020 European Research Council (ERC)/ ; MR/W005611/1//UKRI | Medical Research Council (MRC)/ ; Project No. 2014-2020.4.01.15-0012//EC | H2020 | H2020 Priority Excellent Science | H2020 European Research Council (ERC)/ ; PRG230 and EAG79//Eesti Teadusagentuur (ETAg)/ ; },
mesh = {*COVID-19/metabolism/virology ; CRISPR-Cas Systems ; *Endosomes/virology ; Gene Deletion ; *Host-Pathogen Interactions ; Humans ; Nanoparticles ; *Neuropilin-1/genetics/metabolism ; Proteomics ; *SARS-CoV-2/metabolism ; Sorting Nexins/metabolism ; Spike Glycoprotein, Coronavirus/metabolism ; },
abstract = {Endosomal sorting maintains cellular homeostasis by recycling transmembrane proteins and associated proteins and lipids (termed "cargoes") from the endosomal network to multiple subcellular destinations, including retrograde traffic to the trans-Golgi network (TGN). Viral and bacterial pathogens subvert retrograde trafficking machinery to facilitate infectivity. Here, we develop a proteomic screen to identify retrograde cargo proteins of the endosomal SNX-BAR sorting complex promoting exit 1 (ESCPE-1). Using this methodology, we identify Neuropilin-1 (NRP1), a recently characterized host factor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, as a cargo directly bound and trafficked by ESCPE-1. ESCPE-1 mediates retrograde trafficking of engineered nanoparticles functionalized with the NRP1-interacting peptide of the SARS-CoV-2 spike (S) protein. CRISPR-Cas9 deletion of ESCPE-1 subunits reduces SARS-CoV-2 infection levels in cell culture. ESCPE-1 sorting of NRP1 may therefore play a role in the intracellular membrane trafficking of NRP1-interacting viruses such as SARS-CoV-2.},
}

*COVID-19/metabolism/virology
CRISPR-Cas Systems
*Endosomes/virology
Gene Deletion
*Host-Pathogen Interactions
Humans
Nanoparticles
*Neuropilin-1/genetics/metabolism
Proteomics
*SARS-CoV-2/metabolism
Sorting Nexins/metabolism
Spike Glycoprotein, Coronavirus/metabolism

@article {pmid35695893,
year = {2022},
author = {Coon, BG and Timalsina, S and Astone, M and Zhuang, ZW and Fang, J and Han, J and Themen, J and Chung, M and Yang-Klingler, YJ and Jain, M and Hirschi, KK and Yamamato, A and Trudeau, LE and Santoro, M and Schwartz, MA},
title = {A mitochondrial contribution to anti-inflammatory shear stress signaling in vascular endothelial cells.},
journal = {The Journal of cell biology},
volume = {221},
number = {7},
pages = {},
doi = {10.1083/jcb.202109144},
pmid = {35695893},
issn = {1540-8140},
support = {AHA#13POST16720007//American Heart Association/ ; R01 HL75092/NH/NIH HHS/United States ; //Leducq Trans-Atlantic Network/ ; ERC-CoG 647057/ERC_/European Research Council/International ; 20119//Associazione Italiana Ricerca sul Cancro/ ; //Krembil Foundation/ ; //Fondation Brain Canada/ ; /CAPMC/CIHR/Canada ; },
mesh = {Atherosclerosis/pathology ; CRISPR-Cas Systems ; Calcium Signaling ; *Endothelial Cells/metabolism ; Humans ; Inflammation ; *Kruppel-Like Transcription Factors/genetics/metabolism ; MAP Kinase Kinase 5 ; MAP Kinase Kinase Kinase 2 ; MAP Kinase Kinase Kinase 3 ; *Mitochondria/metabolism ; Mitogen-Activated Protein Kinase 7/genetics/metabolism ; Reactive Oxygen Species ; *Stress, Mechanical ; },
abstract = {Atherosclerosis, the major cause of myocardial infarction and stroke, results from converging inflammatory, metabolic, and biomechanical factors. Arterial lesions form at sites of low and disturbed blood flow but are suppressed by high laminar shear stress (LSS) mainly via transcriptional induction of the anti-inflammatory transcription factor, Kruppel-like factor 2 (Klf2). We therefore performed a whole genome CRISPR-Cas9 screen to identify genes required for LSS induction of Klf2. Subsequent mechanistic investigation revealed that LSS induces Klf2 via activation of both a MEKK2/3-MEK5-ERK5 kinase module and mitochondrial metabolism. Mitochondrial calcium and ROS signaling regulate assembly of a mitophagy- and p62-dependent scaffolding complex that amplifies MEKK-MEK5-ERK5 signaling. Blocking the mitochondrial pathway in vivo reduces expression of KLF2-dependent genes such as eNOS and inhibits vascular remodeling. Failure to activate the mitochondrial pathway limits Klf2 expression in regions of disturbed flow. This work thus defines a connection between metabolism and vascular inflammation that provides a new framework for understanding and developing treatments for vascular disease.},
}

Atherosclerosis/pathology
CRISPR-Cas Systems
Calcium Signaling
*Endothelial Cells/metabolism
Humans
Inflammation
*Kruppel-Like Transcription Factors/genetics/metabolism
MAP Kinase Kinase 5
MAP Kinase Kinase Kinase 2
MAP Kinase Kinase Kinase 3
*Mitochondria/metabolism
Mitogen-Activated Protein Kinase 7/genetics/metabolism
Reactive Oxygen Species
*Stress, Mechanical

@article {pmid35623274,
year = {2022},
author = {Chen, H and Li, ZY and Chen, J and Yu, H and Zhou, W and Shen, F and Chen, Q and Wu, L},
title = {CRISPR/Cas12a-based electrochemical biosensor for highly sensitive detection of cTnI.},
journal = {Bioelectrochemistry (Amsterdam, Netherlands)},
volume = {146},
number = {},
pages = {108167},
doi = {10.1016/j.bioelechem.2022.108167},
pmid = {35623274},
issn = {1878-562X},
mesh = {*Aptamers, Nucleotide ; *Biosensing Techniques/methods ; CRISPR-Cas Systems/genetics ; Electrochemical Techniques/methods ; Humans ; Limit of Detection ; Troponin I ; },
abstract = {The successful fabrication of the cTnI detection platform is very meaningful for instant diagnosis of the myocardialinjury and related cardiovascular diseases (CVDs). In this research work, the magnetic nanoparticles and aptamer collaboration with the Cas12a/crRNA are used for the electrochemical detection of cTnI. The aptamer is hybridized with its partially complementary DNA (probe 2, P2) and then is modified on the magnetic nanoparticles. In the presence of cTnI, the cTnI combines with the aptamer and P2 is released. The released P2 is hybridized with the crRNA and the trans-cleavage activity of CRISPR/Cas12a is triggered. Therefore, the methylene blue-modified DNA (probe1, P1) on the surface of the electrode is cleaved, resulting in the decrease of the electrochemical signal. Based on the synergy effect of the high specific target recognition of aptamer, target-specifically triggering trans-cleavage activity of CRISPR/Cas12a, as well as good separation ability of magnetic nanoparticles, the developed electrochemical biosensor enables to detect cTnI with high specificity and sensitivity. The detection limit is low down to 10 pg/mL with a linear range from 100 pg/mL to 50000 pg/mL. The developed sensing platform was successfully applied for the detection of cTnI in human serum. This fabricated CRISPR/Cas12a-based electrochemical biosensor can offer a valuable tool for the diagnosis, prognosis, and treatment of patient with CVDs.},
}

*Aptamers, Nucleotide
*Biosensing Techniques/methods
CRISPR-Cas Systems/genetics
Electrochemical Techniques/methods
Humans
Limit of Detection
Troponin I

@article {pmid35618221,
year = {2022},
author = {Yu, H and Iqbal, A and Fang, X and Jiang, P and Zhao, Z},
title = {Transcriptome analysis of CRISPR/Cas9-mediated GPAM-/- in bovine mammary epithelial cell-line unravelled the effects of GPAM gene on lipid metabolism.},
journal = {Gene},
volume = {834},
number = {},
pages = {146574},
doi = {10.1016/j.gene.2022.146574},
pmid = {35618221},
issn = {1879-0038},
mesh = {Animals ; CRISPR-Cas Systems ; Cattle ; Epithelial Cells/metabolism ; Fatty Acids/metabolism ; Fatty Acids, Unsaturated/metabolism ; Gene Expression Profiling ; Glycerol-3-Phosphate O-Acyltransferase/genetics ; *Lipid Metabolism/genetics ; *Mammary Glands, Animal/metabolism ; Milk/metabolism ; Phosphates/metabolism ; },
abstract = {Glycerol-3-phosphate acyltransferase mitochondrial (GPAM) is an enzyme in animal lipid metabolism pathways that catalyzes the initial and most committed step of glycerolipid biosynthesis. The present study mainly focused on exploring the relationship between the GPAM gene and the lipid metabolism of mammary epithelial cells and the effect of GPAM on the related pathways of lipid metabolism. The GPAM gene was knocked out entirely in bovine mammary epithelial cells(BMECs) using CRISPR/Cas9 technology, and the mechanism by which the GPAM gene regulates lipid metabolism in BMECs was confirmed. Furthermore, after the complete loss of GPAM, BMECs' triglycerides (TGs) and cholesterol (CHOL) levels were significantly decreased (p < 0.05). Concurrently, the content of octanoic acid, a medium-chain saturated fatty acid, increased substantially in BMECs. RNA-seq of GPAM-/- BMECs revealed that GPAM could affect the expression of genes related to lipid metabolism, downregulated the expression of Acyl-CoA synthetase long-chain family member 5 (ACSL5), Fatty Acid Binding Protein 3 (FABP3), Hormone-sensitive lipase (HSL), Protease, serine-2 (PRSS2), 1-Acylglycerol-3-Phosphate O Acyltransferase 4 (AGPAT4), and regulated the milk synthesis metabolism pathway.The findings revealed that a number of genes were expressed, a number of genes were differentially expressed genes (DEGs), and a number of GO terms were enriched, with a number of GO terms considerably increased. Further, the differentially expressed genes (DEGs) were significantly enriched in Fat digestion and absorption pathway, Fatty acid metabolic pathway, Biosynthesis of unsaturated fatty acids, Biosynthesis of unsaturated fatty acids and steroids, NF-kappa B signalling pathway, MAPK signalling pathway. In conclusion, the current research results show that GPAM is a crucial regulator of BMEC lipid metabolism. GPAM-/- BMEC may also become useful genetic materials and tools for future research on gene functions related to lipid and fatty acid metabolism. This study will contribute to the discovery of gene regulation and molecular mechanisms in milk fat synthesis.},
}

Animals
CRISPR-Cas Systems
Cattle
Epithelial Cells/metabolism
Fatty Acids/metabolism
Fatty Acids, Unsaturated/metabolism
Gene Expression Profiling
Glycerol-3-Phosphate O-Acyltransferase/genetics
*Lipid Metabolism/genetics
*Mammary Glands, Animal/metabolism
Milk/metabolism
Phosphates/metabolism

@article {pmid35617843,
year = {2022},
author = {He, Z and Feng, K and Sun, H and Yu, T and Zhu, D and Yang, Y},
title = {Generation of a human extended pluripotent stem cell line (SKLRMe002-A) carrying a doxycycline-inducible Cas9 expression cassette.},
journal = {Stem cell research},
volume = {62},
number = {},
pages = {102816},
doi = {10.1016/j.scr.2022.102816},
pmid = {35617843},
issn = {1876-7753},
mesh = {CRISPR-Cas Systems/genetics ; Cell Differentiation ; Cell Line ; *Doxycycline/pharmacology ; Humans ; *Pluripotent Stem Cells/metabolism ; },
abstract = {Human extended pluripotent stem cell (hEPS) is a novel type of pluripotent stem cell, which possesses bi-potency towards both embryonic and extraembryonic lineages. Here, we generated a hEPS cell line (hEPS1-iCas9-B) from the cell line named hEPS1, carrying a doxycycline-inducible Cas9 expression cassette along with a constitutive reverse tetracycline transactivator (M2rtTA) expression cassette at the AAVS1 locus, thus we could efficiently generate genetically modified hEPS for studies. This cell lined remained self-renewal, differentiation potential and normal karyotype. Meanwhile, it showed robust transcriptional expression of Cas9 with doxycycline induction and could target the site where the sgRNA guided.},
}

CRISPR-Cas Systems/genetics
Cell Differentiation
Cell Line
*Doxycycline/pharmacology
Humans
*Pluripotent Stem Cells/metabolism

@article {pmid35614226,
year = {2022},
author = {Nusser, A and Sagar, and Swann, JB and Krauth, B and Diekhoff, D and Calderon, L and Happe, C and Grün, D and Boehm, T},
title = {Developmental dynamics of two bipotent thymic epithelial progenitor types.},
journal = {Nature},
volume = {606},
number = {7912},
pages = {165-171},
pmid = {35614226},
issn = {1476-4687},
support = {/ERC_/European Research Council/International ; },
mesh = {Aging ; Animals ; Autocrine Communication ; CRISPR-Cas Systems ; Cellular Microenvironment ; *Epithelial Cells/cytology/metabolism ; Epithelium ; Fibroblast Growth Factor 7 ; Mice ; RNA-Seq ; Single-Cell Analysis ; *Stem Cells/cytology ; *T-Lymphocytes/cytology/metabolism ; *Thymus Gland/cytology ; },
abstract = {T cell development in the thymus is essential for cellular immunity and depends on the organotypic thymic epithelial microenvironment. In comparison with other organs, the size and cellular composition of the thymus are unusually dynamic, as exemplified by rapid growth and high T cell output during early stages of development, followed by a gradual loss of functional thymic epithelial cells and diminished naive T cell production with age1-10. Single-cell RNA sequencing (scRNA-seq) has uncovered an unexpected heterogeneity of cell types in the thymic epithelium of young and aged adult mice11-18; however, the identities and developmental dynamics of putative pre- and postnatal epithelial progenitors have remained unresolved1,12,16,17,19-27. Here we combine scRNA-seq and a new CRISPR-Cas9-based cellular barcoding system in mice to determine qualitative and quantitative changes in the thymic epithelium over time. This dual approach enabled us to identify two principal progenitor populations: an early bipotent progenitor type biased towards cortical epithelium and a postnatal bipotent progenitor population biased towards medullary epithelium. We further demonstrate that continuous autocrine provision of Fgf7 leads to sustained expansion of thymic microenvironments without exhausting the epithelial progenitor pools, suggesting a strategy to modulate the extent of thymopoietic activity.},
}

Aging
Animals
Autocrine Communication
CRISPR-Cas Systems
Cellular Microenvironment
*Epithelial Cells/cytology/metabolism
Epithelium
Fibroblast Growth Factor 7
Mice
RNA-Seq
Single-Cell Analysis
*Stem Cells/cytology
*T-Lymphocytes/cytology/metabolism
*Thymus Gland/cytology

@article {pmid35597342,
year = {2022},
author = {Liu, L and Duan, JJ and Wei, XY and Hu, H and Wang, YB and Jia, PP and Pei, DS},
title = {Generation and application of a novel high-throughput detection based on RPA-CRISPR technique to sensitively monitor pathogenic microorganisms in the environment.},
journal = {The Science of the total environment},
volume = {838},
number = {Pt 2},
pages = {156048},
doi = {10.1016/j.scitotenv.2022.156048},
pmid = {35597342},
issn = {1879-1026},
mesh = {Animals ; CRISPR-Cas Systems ; Nucleic Acid Amplification Techniques/methods ; *Recombinases/genetics ; *Staphylococcal Infections ; Staphylococcus aureus/genetics ; },
abstract = {Staphylococcus aureus (S. aureus) is an important opportunistic human and animal pathogen that can cause a wide diversity of infections. Due to its environmental health risks, it is crucial to establish a time-saving, high-throughput, and highly sensitive technique for water quality surveillance. In this study, we developed a novel method to detect S. aureus in the water environment based on recombinase polymerase amplification (RPA) and CRISPR/Cas12a. This method utilizes isothermal amplification of nucleic acids and the trans-cleavage activity of the CRISPR/Cas12a system to generate fluorescence signals with a single-stranded DNA-fluorophore-quencher (ssDNA-FQ) reporter and a naked-eye detected lateral flow assay (LFA). Our RPA-CRISPR/Cas12a detection system can reduce the detection time to 35 min and enhance the high-throughput detection threshold to ≥5 copies of pathogen DNA, which is more sensitive than that of reported. Moreover, in the lower reaches of the Jialing River in Chongqing, China, 10 water samples from the mainstream and 7 ones from tributaries were successfully monitored S. aureus for less than 35 min using RPA-CRISPR/Cas12a detection system. Taken together, a novel high-throughput RPA-CRISPR detection was established and firstly applied for sensitively monitoring S. aureus in the natural water environment.},
}

Animals
CRISPR-Cas Systems
Nucleic Acid Amplification Techniques/methods
*Recombinases/genetics
*Staphylococcal Infections
Staphylococcus aureus/genetics

@article {pmid35588782,
year = {2022},
author = {Tripathi, R and Sinha, NR and Kempuraj, D and Balne, PK and Landreneau, JR and Juneja, A and Webel, AD and Mohan, RR},
title = {Evaluation of CRISPR/Cas9 mediated TGIF gene editing to inhibit corneal fibrosis in vitro.},
journal = {Experimental eye research},
volume = {220},
number = {},
pages = {109113},
doi = {10.1016/j.exer.2022.109113},
pmid = {35588782},
issn = {1096-0007},
mesh = {Actins/genetics/metabolism ; CRISPR-Cas Systems ; Cell Differentiation ; Cells, Cultured ; Co-Repressor Proteins/genetics/metabolism ; Collagen/metabolism ; *Corneal Diseases/pathology ; Fibroblasts/metabolism ; Fibrosis ; *Gene Editing ; Homeodomain Proteins ; Humans ; Myofibroblasts/metabolism ; Repressor Proteins/metabolism ; Transcription Factors/genetics ; Transforming Growth Factor beta1/pharmacology ; },
abstract = {Corneal wound healing is influenced by many factors including transcriptional co-repressors and co-activators. Interactions of co-activators and co-repressors with Smads influence mechanistic loop facilitating transcription of alpha-smooth muscle actin (α-SMA), a key profibrotic gene, in corneal repair. The role of a transcriptional repressor, 5'TG3'-interacting factor (TGIF), in the regulation of α-SMA and myofibroblast formation in the cornea was shown previously by our group. This study tested a hypothesis if TGIF1 gene editing via CRISPR/Cas9 can ease myofibroblast formation in the cornea using an in vitro model. Primary human corneal stromal fibroblasts (hCSFs) generated from donor corneas received gene-editing plasmid facilitating loss (CRISPR/Cas9 knockout) or gain (CRISPR activation) of TGIF function by UltraCruz transfection reagent. Phase-contrast microscopy, immunoblotting, immunocytochemistry and quantitative polymerase chain reaction (qPCR) were used to measure levels of myofibroblast profibrotic genes (α-SMA, fibronectin, Collagen-I, and Collagen-IV) in hCSFs lacking or overexpressing TGIF1 after growing them in± transforming growth factor beta1 (TGF-β1) under serum-free conditions. The CRISPR-assisted TGIF1 activation (gain of function) in hCSFs demonstrated significantly decreased myofibroblast formation and messenger ribonucleic acid (mRNA) and protein levels of profibrotic genes. Conversely, CRISPR/Cas9-assisted TGIF knockdown (loss of function) in hCSFs demonstrated no significant change in the levels of myofibroblast formation or profibrotic genes under similar conditions. These results suggest that TGIF gene-editing approach can be employed to modulate the transcriptional activity of α-SMA in controlling pathological and promoting physiological wound healing in an injured cornea.},
}

Actins/genetics/metabolism
CRISPR-Cas Systems
Cell Differentiation
Cells, Cultured
Co-Repressor Proteins/genetics/metabolism
Collagen/metabolism
*Corneal Diseases/pathology
Fibroblasts/metabolism
Fibrosis
*Gene Editing
Homeodomain Proteins
Humans
Myofibroblasts/metabolism
Repressor Proteins/metabolism
Transcription Factors/genetics
Transforming Growth Factor beta1/pharmacology

@article {pmid35588272,
year = {2022},
author = {Meliawati, M and May, T and Eckerlin, J and Heinrich, D and Herold, A and Schmid, J},
title = {Insights in the Complex DegU, DegS, and Spo0A Regulation System of Paenibacillus polymyxa by CRISPR-Cas9-Based Targeted Point Mutations.},
journal = {Applied and environmental microbiology},
volume = {88},
number = {11},
pages = {e0016422},
doi = {10.1128/aem.00164-22},
pmid = {35588272},
issn = {1098-5336},
mesh = {Bacillus subtilis/genetics ; Bacterial Proteins/genetics/metabolism ; CRISPR-Cas Systems ; *Paenibacillus polymyxa/genetics/metabolism ; Point Mutation ; },
abstract = {Despite being unicellular organisms, bacteria undergo complex regulation mechanisms which coordinate different physiological traits. Among others, DegU, DegS, and Spo0A are the pleiotropic proteins which govern various cellular responses and behaviors. However, the functions and regulatory networks between these three proteins are rarely described in the highly interesting bacterium Paenibacillus polymyxa. In this study, we investigate the roles of DegU, DegS, and Spo0A by introduction of targeted point mutations facilitated by a CRISPR-Cas9-based system. In total, five different mutant strains were generated, the single mutants DegU Q218*, DegS L99F, and Spo0A A257V, the double mutant DegU Q218* DegS L99F, and the triple mutant DegU Q218* DegS L99F Spo0A A257V. Characterization of the wild-type and the engineered strains revealed differences in swarming behavior, conjugation efficiency, sporulation, and viscosity formation of the culture broth. In particular, the double mutant DegU Q218* DegS L99F showed a significant increase in conjugation efficiency as well as a stable exopolysaccharides formation. Furthermore, we highlight similarities and differences in the roles of DegU, DegS, and Spo0A between P. polymyxa and related species. Finally, this study provides novel insights into the complex regulatory system of P. polymyxa DSM 365. IMPORTANCE To date, only limited knowledge is available on how complex cellular behaviors are regulated in P. polymyxa. In this study, we investigate several regulatory proteins which play a role in governing different physiological traits. Precise targeted point mutations were introduced to their respective genes by employing a highly efficient CRISPR-Cas9-based system. Characterization of the strains revealed some similarities, but also differences, to the model bacterium Bacillus subtilis with regard to the regulation of cellular behaviors. Furthermore, we identified several strains which have superior performance over the wild-type. The applicability of the CRISPR-Cas9 system as a robust genome editing tool, in combination with the engineered strain with increased genetic accessibility, would boost further research in P. polymyxa and support its utilization for biotechnological applications. Overall, our study provides novel insights, which will be of importance in understanding how multiple cellular processes are regulated in Paenibacillus species.},
}

Bacillus subtilis/genetics
Bacterial Proteins/genetics/metabolism
CRISPR-Cas Systems
*Paenibacillus polymyxa/genetics/metabolism
Point Mutation

@article {pmid35586918,
year = {2022},
author = {He, D and Liu, G and Yang, J and Jiang, X and Wang, H and Fan, Y and Gong, S and Wei, F and Diao, Y and Tang, Y},
title = {Specific High-Sensitivity Enzymatic Molecular Detection System Termed RPA-Based CRISPR-Cas13a for Duck Tembusu Virus Diagnostics.},
journal = {Bioconjugate chemistry},
volume = {33},
number = {6},
pages = {1232-1240},
doi = {10.1021/acs.bioconjchem.2c00200},
pmid = {35586918},
issn = {1520-4812},
mesh = {CRISPR-Cas Systems/genetics ; *Clustered Regularly Interspaced Short Palindromic Repeats ; *Flavivirus/genetics ; RNA ; Recombinases ; },
abstract = {In China, drastic losses in the economy have been caused by the Tembusu virus (TMUV), the causative agent of the egg-drop syndrome, to the duck-raising industry. To succeed in preventing and controlling infections, extant techniques must be upgraded to achieve fast detection of viruses. This work is the first attempt to present the development of a recombinase polymerase amplification (RPA)-based clustered regularly interspaced short palindromic repeats (CRISPRs)-Cas13a approach for the TMUV infection diagnosis, where the CRISPR-Cas13a system is exploited, i.e., the programmability of CRISPR RNA (crRNA) and the promiscuous RNase collateral cleavage of Cas13a upon recognition of target RNAs. A prokaryotic expression system was utilized for the expression of LwCas13a soluble protein, while its purification was accomplished by nickel-nitrilotriacetic acid (Ni-NTA) agarose. In the design of a particular crRNA, the target used was the TMUV NS3 RNA transcribed in vitro. The signals used for the Cas13a activity validation were an RNA-bound fluorescent group (single-stranded) and a quenching fluorophore. In the present work, a specific high-sensitivity enzymatic molecular detection system termed RPA-based CRISPR-Cas13a was established by combining Cas13a with T7 transcription and RPA for sensitive detection of TMUV at room temperature. This system can detect 102 copies of the target TMUV DNA standard/μL within 50 min. A comparison revealed that the specificity was superior to that for other avian viruses. Furthermore, the RPA-based CRISPR-Cas13a detection system was successfully applied for clinical samples, and its performance is comparable to the reverse-transcriptase real-time quantitative polymerase chain reaction (RT-qPCR). Being satisfyingly reliable, simple, specific, and sensitive, our RPA-based CRISPR-Cas13a detection system could be expanded and universalized for identifying other viruses, enabling quick detection in the field with a portable lateral flow dipstick.},
}

CRISPR-Cas Systems/genetics
*Clustered Regularly Interspaced Short Palindromic Repeats
*Flavivirus/genetics
RNA
Recombinases

@article {pmid35581476,
year = {2022},
author = {Tringe, SG},
title = {A toolkit for microbial community editing.},
journal = {Nature reviews. Microbiology},
volume = {20},
number = {7},
pages = {383},
pmid = {35581476},
issn = {1740-1534},
mesh = {*CRISPR-Cas Systems ; Gene Editing ; *Microbiota ; },
}

*CRISPR-Cas Systems
Gene Editing
*Microbiota

@article {pmid35578739,
year = {2022},
author = {Mu, K and Ren, X and Yang, H and Zhang, T and Yan, W and Yuan, F and Wu, J and Kang, Z and Han, D and Deng, R and Zeng, Q},
title = {CRISPR-Cas12a-Based Diagnostics of Wheat Fungal Diseases.},
journal = {Journal of agricultural and food chemistry},
volume = {70},
number = {23},
pages = {7240-7247},
doi = {10.1021/acs.jafc.1c08391},
pmid = {35578739},
issn = {1520-5118},
mesh = {CRISPR-Cas Systems ; *Fusarium/metabolism ; *Mycoses/genetics ; Plant Diseases/microbiology ; RNA, Guide/metabolism ; Triticum/genetics/microbiology ; },
abstract = {Fusarium head blight (FHB) of wheat, mainly caused by Fusarium graminearum (F. graminearum) infection, reduces crop yield and contaminates grain with mycotoxins. We report a clustered regularly interspaced short palindromic repeats (CRISPR)-Cas12a-based nucleic acid assay for an early and rapid diagnosis of wheat FHB. Guide RNA (gRNA) was screened for highly specific recognition of polymerase chain reaction (PCR) amplicon of the internal transcribed spacer (ITS) region and the transcription elongation factor 1α (EF1α) of F. graminearum. The trans-activation of Cas12a protein cleaves the single-stranded DNA probes with the terminal fluorophore and quencher groups, thus allowing us to report the presence of ITS and EF1α of F. graminearum. Owing to the dual recognition process through PCR primers and gRNA hybridization, the approach realized specific discrimination of F. graminearum from other pathogenic fungi. It also allowed us to detect as low as 1 fg/μL total DNA from F. graminearum, which is sufficient to diagnose a 4 day F. graminearum infection. CRISPR-Cas12a-based nucleic acid assay promises the molecular diagnosis of crop diseases and broadens the application of CRISPR tools.},
}

CRISPR-Cas Systems
*Fusarium/metabolism
*Mycoses/genetics
Plant Diseases/microbiology
RNA, Guide/metabolism
Triticum/genetics/microbiology

@article {pmid35576811,
year = {2022},
author = {Gulimiheranmu, M and Li, S and Zhou, J},
title = {Generation of a MIR5004 knockout cell line from human induced pluripotent stem cells by CRISPR/Cas9 gene editing.},
journal = {Stem cell research},
volume = {62},
number = {},
pages = {102805},
doi = {10.1016/j.scr.2022.102805},
pmid = {35576811},
issn = {1876-7753},
mesh = {CRISPR-Cas Systems/genetics ; Cell Differentiation/genetics ; Cell Line ; *Gene Editing ; Humans ; *Induced Pluripotent Stem Cells/metabolism ; },
abstract = {MIR5004 is located in the intronic region of SYNGAP1, a genetic risk factor for Autism Spectrum Disorders (ASD), and co-expressed with SYNGAP1 in brain tissue, which indicates that MIR5004 may play an important role in ASD pathogenesis through the regulation of SYNGAP1. Here, we generated a MIR5004 knockout human induced pluripotent stem cell (iPSC) line SHCDCLi001-B. SHCDCLi001-B shows expression of pluripotent markers, three lineage differentiation capacity, normal morphology and karyotypes, the same DNA origin with wild type iPSC (iPSC-WT) and no off-target effects, making it as a valuable tool for studying the interplay between MIR5004 and SYNGAP1 in ASD pathogenesis.},
}

CRISPR-Cas Systems/genetics
Cell Differentiation/genetics
Cell Line
*Gene Editing
Humans
*Induced Pluripotent Stem Cells/metabolism

@article {pmid35567848,
year = {2022},
author = {Zhang, D and Zhou, M and Zhang, Y and Shan, Y and Pan, G},
title = {Generation of an RNF1-deficient human pluripotent stem cell line using CRISPR/Cas9 technology.},
journal = {Stem cell research},
volume = {62},
number = {},
pages = {102809},
doi = {10.1016/j.scr.2022.102809},
pmid = {35567848},
issn = {1876-7753},
mesh = {CRISPR-Cas Systems/genetics ; Cell Differentiation/physiology ; Cell Line ; *Human Embryonic Stem Cells/metabolism ; Humans ; *Pluripotent Stem Cells ; Technology ; },
abstract = {RNF1 (RING1A) is a catalytic component of the polycomb repressive complex 1 (PRC1) involved in regulation of, among others, embryonic development and disease progression. However, the exact role of RNF1 in self-renewal and differentiation of human embryonic stem cells (ESCs) remains unknown. Here, we derive one RNF1 knockout human ESC line using CRISPR/Cas9 system. The cell line retains the canonical stem cell morphology and normal karyotype. Moreover, the cell line highly expresses pluripotency genes and has three germ-layer differentiation potential. The RNF1 -/- cell line will be useful for studies on the function and role of RNF1 in human embryonic stem cell fate decisions.},
}

CRISPR-Cas Systems/genetics
Cell Differentiation/physiology
Cell Line
*Human Embryonic Stem Cells/metabolism
Humans
*Pluripotent Stem Cells
Technology